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ABSTRACT 
 
The onset of schizophrenia before the age of 18 is commonly categorized as early onset 
schizophrenia. It accounts for less than 4% of all cases of schizophrenia, the prevalence 
of which is about 1% worldwide. Premorbid abnormalities seem to be very typical, and 
prognosis is often poor. Besides the negative and positive symptoms, severe 
neurocognitive deficits also occur.  
Schizophrenia and pervasive developmental disorders share a common history. From 
1970 onwards these disorders have been regarded as separate conditions. These 
disorders have different ages of onset as well as developmental courses. Nevertheless, 
the clinical symptoms as well as the results of genetic and neuroimaging studies 
overlap.  
The participants in this thesis were adolescent schizophrenia patients (n = 18; 7 
males, 11 females). The mean age of the participants at recruitment was 15.6 years 
(studies I-III) and at the time of psychological assessment 16.2 years (study IV). Study 
IV also included 15 adolescents with PDD without psychotic disorder (n = 15; 7 males, 
8 females). Their mean age at recruitment was 16.1 years. All participants had a primary 
IQ over 70.    
Study I of this thesis assessed the possible comorbidity of early onset schizophrenia 
and pervasive developmental disorders. We found that a total of 44% of adolescents 
with schizophrenia had some pervasive developmental disorder already in childhood. 
However, most of the adolescents had a correct comorbid diagnosis until the onset of 
psychotic symptoms and the diagnosis of schizophrenia.  
Study II evaluated the number and nature of catatonic features among adolescents 
with schizophrenia. A further comparison was made of the nature and numbers of those 
features between adolescents suffering from schizophrenia alone and those 
schizophrenia patients with comorbid pervasive developmental disorder. All adolescents 
with schizophrenia presented many lifetime catatonic features. Adolescents with 
schizophrenia and comorbid pervasive developmental disorder had an earlier onset of 
catatonic features, more catatonic features and a greater variety of catatonic features 
compared to schizophrenia patients without comorbidity.    
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Study III aimed to assess the developmental skills of adolescents with schizophrenia. 
All of the adolescents with schizophrenia exhibited some developmental delays. 
Adolescents with schizophrenia and comorbid pervasive developmental disorders 
exhibited more delays in developmental skills than did those schizophrenia adolescents 
without comorbidity.  
Study IV investigated neurocognition and social cognition between adolescents 
suffering from schizophrenia alone, those schizophrenia patients with comorbid 
pervasive developmental disorder and adolescents with pervasive developmental 
disorder only. The profiles of the neurocognitive abilities and disabilities between these 
three groups differed. The adolescents with schizohrenia and comorbid pervasive 
developmental disorder did not have more severe problems than the other two groups. 
The comorbid group displayed a combination of the visual strengths those are typical 
for PDDs and the deficits in processing speed associated with schizophrenia. 
These study findings showed that among adolescents with early onset schizophrenia 
is a subgroup of adolescents with comorbid pervasive developmental disorder. The 
symptoms of these adolescents seem to be more severe, and this subgroup should be 
taken into account in psychiatric services and rehabilitation.  
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TIIVISTELMÄ 	  
Skitsofrenian esiintyvyys on maailmanlaajuisesti noin 1 %. Ennen 18 ikävuotta 
puhkeavaa skitsofreniaa kutsutaan varhain alkavaksi skitsofreniaksi. Sen 
esiintyvyydeksi on arvioitu alle 4 % kaikista skitsofreniatapauksista. Varhain 
puhkeavalle skitsofrenialle tyypillisiä piirteitä ovat kehitykselliset poikkeavuudet ennen 
psykoosioireiden puhkeamista sekä huono ennuste. Negatiivisten ja positiivisten 
oireiden lisäksi sairauteen liittyy merkittäviä neurokognitiivisia poikkeavuuksia.  
Skitsofrenialla ja laaja-alaisilla kehityshäiriöillä on pitkä yhteinen historia.  Vasta 
1970-luvulta lähtien nämä häiriöt on virallisissa diagnoosijärjestelmissä erotettu 
toisistaan. Oirekuvien puhkeamisikä ja taudin kehityskulku poikkeavat toisistaan, mutta 
sekä kliinisessä oirekuvassa että geeni- että neurokuvantamistutkimusten tuloksissa 
esiintyy paljon päällekkäisyyttä.  
Tämän väitöskirjan tutkimuskohteen muodostivat skitsofreniaan sairastuneet nuoret 
(n = 18; 7 poikaa, 11 tyttöä), joiden keski-ikä oli 15.6 vuotta (Osajulkaisuissa I-III) ja 
psykologisen tutkimuksen aikaan 16.2 vuotta (Osajulkaisu IV). Osajulkaisussa IV oli 
mukana myös 15 nuorta, joilla oli diagnosoitu laaja-alainen kehityshäiriö, mutta ei 
psykoosisairautta (n = 15; 7 poikaa, 8 tyttöä). Heidän keski-ikänsä oli 16.1 vuotta. 
Kaikkien tutkittavien primaari älykkyysosamäärä oli yli 70.   
Väitöskirjan ensimmäisessä osatyössä selvitettiin, mikä on varhain alkavan 
skitsofrenian ja laaja-alaisten kehityshäiriöiden yhteissairastavuus. Tutkimuksessamme 
44%:lla nuorista skitsofreniapotilaista esiintyi samanaikainen laaja-alainen 
kehityshäiriö. Kuitenkin suurimmalle osalle nuorista kyseinen diagnoosi asetettiin vasta 
skitsofrenian puhkeamisen yhteydessä.  
Toinen osatyö selvitti skitsofreniaa sairastavien nuorten katatonisten oireiden määrää 
ja laatua. Lisäksi vertailtiin katatonisten oireiden määrää ja laatua niillä nuorilla, jotka 
sairastivat ainoastaan skitsofreniaa ja niillä, jotka sairastivat sekä skitsofreniaa että 
samanaikaista laaja-alaista kehityshäiriötä. Skitsofreniaan sairastuneilla nuorilla esiintyi 
runsaasti katatonisia oireita. Nuorilla, joilla oli sekä skitsofrenia että laaja-alainen 
kehityshäiriö, katatonisia piirteitä esiintyi nuoremmalla iällä, oireita oli enemmän ja ne 
olivat laaja-alaisempia verrattuna nuoriin, joilla sairastivat pelkästään skitsofreniaa. 
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Kolmas osatyö keskittyi tutkimaan skitsofreniaan sairastuneiden nuorten 
kehityksellisiä taitoja. Kaikilla skitsofreniaan sairastuneilla nuorilla oli havaittavissa 
viiveitä kehityksellisissä taidoissa. Ne nuoret, jotka sairastivat sekä skitsofreniaa että 
samanaikaista laaja-alaista kehityshäiriötä omasivat enemmän viiveitä kehityksellisissä 
taidoissaan kuin ne nuoret, jotka sairastivat ainoastaan skitsofreniaa. 
Neljännessä osatyössä tutkimuksen kohteena oli neurokognitio sekä sosiaalinen 
kognitio.	   Vertailuryhmät muodostivat nuoret, jotka sairastivat skitsofreniaa, nuoret, 
jotka sairastivat sekä skitsofreniaa että laaja-alaista kehityshäiriötä sekä nuoret, joilla oli 
diagnosoitu laaja-alainen kehityshäiriö ilman skitsofreniaa. Ryhmien neurokognitiiviset 
suoritusprofiilit erosivat toisistaan. Ongelmat eivät olleet laaja-alaisempia niillä 
nuorilla, jotka sairastivat sekä skitsofreniaa että laaja-alaista kehityshäiriötä. Heidän 
suoriutumisessaan näkyi laaja-alaisille kehityshäiriöille tyypillinen visuaalinen vahvuus 
ja toisaalta skitsofreniaan liitetty prosessointinopeuden heikkous. 
Nämä tulokset osoittivat, että varhain alkavaan skitsofreniaan sairastuneiden nuorten 
joukossa on alaryhmä, jolla on samanaikainen laaja-alainen kehityshäiriö. Tämän 
alaryhmän oirekuva näyttäytyy vaikeampana ja tämä ryhmä tulisi huomioida 
psykiatrisissa hoito- ja kuntoutuspalveluissa. 
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1 INTRODUCTION  	  
Schizophrenia and pervasive developmental disorders share a long common history. 
Schizophrenia and autism have been regarded as separate conditions since the 1970s. 
Despite the fact that these two conditions are separate entities, the question about the 
distinction between these disorders has arisen again in recent years. Participants in the 
research studies that this thesis summarizes were adolescent patients with schizophrenia 
and/or pervasive developmental disorder. We chose to study this particular age group 
because there is a paucity of published study results in adolescents, in contrast to the 
published studies that exist on children and adults with the same conditions. Indeed we 
are not aware of any previous published studies on adolescents with schizophrenia and 
comorbid pervasive developmental disorder. 
 
1.1 Schizophrenia 
Schizophrenia (SCH) is a severe, pervasive mental disorder with a prevalence of about 
1% worldwide (McDonell & McClellan, 2007). This overall disorder is divided into 
subcategories in the International Classification of Diseases 10th edition (ICD-10), 
namely; paranoid, hebephrenic, catatonic and undifferentiated type of SCH, 
undifferentiated SCH, post-schizophrenic depression and residual SCH. The disorder is 
more common (male: female ratio = 1.4) among males (McGrath, 2006). SCH is a 
heterogeneous disorder with multiple etiologies. Currently no single cause for the 
disorder has been identified (McClellan & Stock, 2013).  
The onset of the disorder is usually in early adulthood and symptoms are divided into 
positive and negative domains. Prominent hallucinations, delusions, disorganized 
speech or behavior or catatonia are categorized as positive symptoms and negative 
symptoms include marked apathy, paucity of speech, and blunting or incongruity of 
emotional responses. After the onset of the disorder social and occupational dysfunction 
also occurs (WHO, 1992). Antipsychotic medication is essential treatment for positive 
symptoms. Medication or psychological interventions has limited effects on negative 
symptoms however (Fusar-Poli et al., 2014). Negative symptoms are associated with 
cognitive disability, especially deficits in verbal memory (Puig et al., 2008; Villalta-Gil 
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et al., 2006). Negative symptoms and cognitive deficits, are associated with disability in 
functioning. Patients with SCH have not shown significant improvement in cognitive 
deficits with antipsychotic treatment (Bowie et al., 2012).  
The disorder has different phases. Prior to the onset of psychotic symptoms most 
individuals will experience a prodrome period during which functions will begin to 
deteriorate. The acute phase is dominated by positive psychotic symptoms. Then active 
psychosis begins to remit, which characterizes the recovery phase that follows on. This 
is in turn followed by the residual phase during which negative symptoms are present 
but positive symptoms are minimal. Usually these phases follow each other in cycles, 
and they show an increasing deterioration trend in each cycle.   
Symptom criteria for SCH in ICD-10 and Diagnostic and Statistical Manual of 
Mental Disorders 4th Edition (DSM-IV) classifications (Table 1) are similar to each 
other, except for the requirement for duration of symptoms. The requirement is at least 
one month in the ICD-10 classification whereas it is six months in the DSM-IV 
classification. There are only a few changes in the Diagnostic and Statistical Manual of 
Mental Disorders 5th Edition (DSM-5) criteria from the previous version: a rise of 
symptom threshold from one specified symptom to two is one major difference. The 
diagnostic criteria no longer identify subtypes. There is also a change in the present 
requirement for positive symptoms: a patient must now have at least one of three 
“positive” symptoms (hallucinations, delusions, disorganized speech; American 
Psychiatric Association, 2013). The diagnostic criteria are the same for the children, 
adolescents and adults.  
Onset of SCH before 13 years of age is quite rare (McClellan & Stock, 2013). One 
early form of SCH has an insidious onset in most cases and it can be referred as 
childhood-onset schizophrenia (COS). The prevalence of COS is 1 in 10 000 children 
(Remschmidt & Theisen, 2005).  
Onset of SCH before the age of 18 is commonly categorized as early onset 
schizophrenia (EOS). It is characterized by either an acute or gradual onset. There is a 
remarkable increase in SCH frequency between 13 and 18 years of age (Remschmidt & 
Theisen, 2005) with the prevalence of SCH-related disorders in adolescence of about 1–
2% (Kessler et al., 1994; Patel et al., 2007). EOS accounts for less than 4% of all cases 
of SCH (Vyas et al., 2011).   
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Premorbid abnormalities such as delays in development, behavioral problems, motor 
problems and language problems seems to be very typical for EOS, especially for COS 
patients (Alaghband-Rad et al., 1995; Schaeffer & Ross, 2002). Over half of the patients 
with COS had premorbid language, motor, and social impairments according to a cohort 
study (Nicolson et al., 2000). However, delays in language and motor developments 
were found only in 10% of individuals who later developed AOS in the 1946 British 
Birth Cohort (Jones et al., 1994). Prognosis of EOS is often poor (Clemmensen et al., 
2012; Hallerbäck et al., 2012; Rapoport et al., 2009), but the same types of 
neurobiological correlates and phenotypic deficits are seen in EOS as in adult-onset 
schizophrenia (AOS) (Vyas et al., 2011). However, some genetic variations, for 
example a 22q11 deletion, may occur more frequently in EOS and COS patients than in 
AOS patients (Vyas et al., 2011). 
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1.2 Pervasive developmental disorders  
The symptomatology for pervasive developmental disorders (PDD) was described by 
Leo Kanner (1943). That author stated that PDD begins during the child’s first years 
and typical characters are social withdrawal, obsessiveness, stereotypy and echolalia. 
Symptoms are quite stable during that time. A year later Hans Asperger (1944) 
introduced quite similar symptomatology of which the most obvious characteristic is 
impairment of reciprocal social interaction. Other characteristics described by Asperger 
were: repetitive activities, problems in non-verbal communication and motor co-
ordination.  
Asperger’s disorder (AS), childhood autism and atypical autism were classified as 
PDDs in ICD-10 (WHO, 1992) and in DSM-IV (American Psychiatric Association, 
1994). The other eight subgroups of PDDs in the ICD-10 classification (F84.0) are 
Rett’s syndrome, childhood disintegrative disorder, overactive disorder associated with 
mental retardation and stereotyped movement, other pervasive developmental disorders 
and pervasive developmental disorder unspecified (residual category). Recently there 
have been major changes in diagnostic categories since the introduction of DSM-5 
(Table 2; American Psychiatric Association, 2013). A new umbrella term, Autism 
spectrum disorder, has replaced all the previous mentioned subgroups. Rett’s syndrome 
is caused by mutations in the X-linked gene encoding methyl-CpG-binding protein 2 
(MeCP2). This syndrome differs from other subgroups of PDD because Autism 
spectrum disorder is defined by specific symptoms in behaviors, not etiologies. Those 
patients who met Rett’s syndrome criteria in DSM-IV can be described in DSM-5 under 
“Autism spectrum disorder”, but the specifier term “ with known genetic or medical 
condition” should be used. The term PDD has been used throughout this text as being 
equivalent with the terms autistic spectrum disorder and autism spectrum disorder 
(ASD) used by Lorna Wing, long before DSM-5 was published. Wing’s term covers the 
range of presentation from classic autism described by Kanner to Asperger’s disorder. 
The triad of impairments is characteristic of Wing’s description of ASD, and in DSM-5 
the triad has been changed to a dyad, by combing two symptoms. 
Prevalence of PDDs is 0.6–1% of the children in general population (Baird et al., 
2006; Fernell & Gillberg, 2010; Nygren et al., 2012). All the PDDs were reported to be 
more common among males than among females (male: female 123.2:30.8) in a study 
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(Gillberg et al., 2006). There has been an increase in prevalence of PDD rates during the 
past decades because of changes in diagnostic criteria, concepts, definitions and changes 
in the policies for special education and the increasing availability of services 
(Fombonne, 2009). 
The etiology of these complex neurodevelopmental disorders remains unclear 
although many candidate genes have been reported (Piggot et al., 2009). There is 
increasing evidence for PDDs genetic heterogeneity (Kim & Leventhal, 2015). 
The diagnosis of PDD is made on the basis of behavioral symptoms and same 
diagnostic criteria apply to children and adults. The onset of PDDs occurs in infancy 
and diagnosis is usually made during early childhood. Nevertheless, it is common that 
diagnosis is also made later (Begeer et al., 2013). The ICD-10 and DSM-IV classified 
PDDs share a core triad of abnormalities: 1) qualitative impairments in reciprocal social 
interactions, 2) qualitative impairments in verbal and non-verbal communication, and 3) 
restricted social imagination with repetitive and stereotyped patterns of interests and 
behavior (WHO, 1992). 
The diagnosis of childhood autism (Table 3) requires the manifestation of abnormal 
or impaired development before the age of three years at least in one of the following 
areas: social communication, the development of selective social attachments, 
reciprocal social interaction or functional or symbolic play. In the case of atypical 
autism atypicality can occur in age of onset, in symptomatology or in both the age of 
onset and symptomatology (WHO, 1992). 
There is not any clinically significant general delay in spoken or receptive language 
or cognitive development in AS. There are qualitative abnormalities in reciprocal social 
interactions in AS that are similar to autism and an unusually intense circumscribed 
interest or restricted, repetitive, and stereotyped patterns of behavior, interests and 
activities can also occur. 
AS is often regarded as same condition as high functioning autism (HFA). Language 
development in childhood in HFA is delayed whereas in AS, the child’s language 
development is normal. However, the study results about differences between these two 
conditions are very heterogeneous. Some studies show that individuals with AS have 
significantly higher full-scale intelligence quotient (IQ), verbal IQ (VIQ), and 
performance IQ (PIQ) with significantly higher VIQ than PIQ than individuals with 
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HFA, whereas VIQ in HFA is similar to PIQ (Chiang et al., 2014). Differences in grey 
and white matter volumes have also been reported (McAlonan et al., 2008; McAlonan et 
al., 2009). However, other studies indicate that there are no differences between AS and 
HFA children for non-verbal, motor or psychosocial adaptation (Noterdaeme et al., 
2010; Ozonoff et al., 2000) and that these conditions have the same fundamental 
symptomatology (Ozonoff et al., 2000). There are no differences in theory of mind 
(ToM) performance in adults with AS and HFA (Spek et al., 2010). Thus, it is quite 
difficult to foresee the clear developmental trajectory of a single individual in the 
transition from childhood into adulthood based on childhood symptomatology. There 
are no qualitatively separable subcategories under Autism spectrum disorders in DSM-5 
the classification. 
1.2.1 Comorbidity 
Within the ICD-10 classification “childhood autism exclusion criteria” states that the 
clinical picture is not attributable to SCH (F20) of unusually early onset. Likewise, 
simple SCH has been excluded for AS criteria (F20.6). Despite the fact that ICD-10 
states that SCH is an exclusion criterion for PDD, many studies agree that these 
disorders can coexist (Hallerbäck et al., 2012; Rapoport et al., 2009). Patients with PDD 
may get the additional diagnosis of SCH, if they have prominent positive symptoms 
(hallucinations and delusions) for at least one month and if the onset of PDD clearly 
precedes the onset of SCH. 
The comorbidity criterion in DSM-5 has been re-evaluated and there is no longer the 
restriction about comorbidity of these two disorders. Deficits in social interaction and 
impairments of communication detailed in DSM-5 have been combined into deficits in 
social communication and social interaction. Symptom severity is evaluated on three 
levels and sensory problems are added to the criteria. There is also the new diagnosis of 
Social (Pragmatic) Communication Disorder under heading 315.39 of DSM-5, which 
differs from Autism spectrum disorder in a lack of restricted/repetitive patterns of 
behavior, interest, and activities during the early development.  
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1.2.2 Treatment 
PDD is a lifelong disorder in which even individuals with high cognitive abilities have 
significant disadvantages regarding social relationships, employment, physical and 
mental health and quality of life (Howlin & Moss, 2012). Core symptoms of PDDs 
respond poorly to medication (Ghaziuddin, 2005). Early interventions when the child is 
under two years of age, are reported to be effective because there is evidence of 
neuroplasticity and critical periods of development in infancy. These interventions are 
usually parent-mediated procedures (Bradshaw et al., 2014) that are intended to develop 
optimal outcome for infants and toddlers with PDD and their families. Often core 
features such as deficits in communication, language or social skills are put under 
scrutiny by the child’s caregiver and behavioral interventions strategies or positive 
behavior support are used (Boyd et al., 2010). Deficits in social skills render individuals 
with PDD vulnerable to depression and anxiety. There is evidence that Cognitive 
behavior therapy (CBT) has potential in treating those patients with PDD who have 
symptoms of depression and stress (McGillivray & Evert, 2014).	  
It is usual that coexisting/comorbid medical conditions, psychiatric disorders and 
behavioral and motor dyscontrol symptoms are associated with autism and AS. 
Coexisting conditions such as depression, tics, Tourette’s, ADHD, catatonic motor 
behavior, obsessions and compulsions and psychotic disorders can be treated with 
medications (Ghaziuddin, 2005; Gillberg & Billstedt, 2000). 	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1.3 Common history of SCH and PDDs  
De Sanctis published case reports between 1906 and 1909 about young children who 
had relatively normal development at first and then underwent marked changes that 
occurred, abruptly or gradually. He named this disorder “dementia praecosissima”. 
These children had catatonic symptoms, negativism, emotional blunting and outbursts 
of anger (Lay, 1938). Emil Kraepelin observed similar cases and named the condition as  
“dementia praecox”. The patients had early onset of the illness and prognosis was poor 
with a progressively deteriorating course (Berrios et al., 2003). Eugen Bleuler 
introduced term schizophrenia in 1911 and started to call the former condition  
“dementia praecox” by that term (Bleuler, 1950). He also used the term autism in 
reference to isolation of the self from social interaction as one of the core symptoms of 
SCH. He described autistic thinking thus: “The autistic thinking is the source of the 
delusions, of the crude offenses against logic and propriety, and all the other 
pathological symptoms” (Bleuler, 1950). 
In 1943 Leo Kanner described a condition that differed in certain respects from 
previously reported cases, and named this condition early infantile autism. He presented 
the history of eight boys and three girls, all under 11 years of age. Kanner reported that 
two of his case patients had earlier been considered as schizophrenic. Kanner made a 
clear distinction between the schizophrenic withdrawal from formerly existing 
participation and the “extreme autistic aloneness these children seem to have from the 
beginning of their lives” (Kanner, 1943).  
A year later in 1944, Hans Asperger also described a new disorder “autistic 
psychopathy” (Asperger, 1944), deriving its name from the concept of autism in SCH. 
According to Asperger, children showed characteristic features from the second year of 
life, which remain constant throughout the life span. The fundamental feature of the 
disorder is a limitation in the social relationships of the patients. Children described by 
Asperger had better cognitive abilities than those described by Kanner. Those studies 
were originally written in German and were translated into English by Lorna Wing in 
1981 (Wing, 1981). She made this disorder more widely known almost 40 years since it 
had first been described. According to Wolff (1996), Eva Ssuchareva described children 
with similar behavior and symptoms and signs as those described by Asperger and 
named the condition “schizoid personality disorder of childhood” (SPDC) as early as 
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1926. Wolff and Barlow (1979) also used the term “schizoid personality in childhood” 
and they were the first researchers to compare SPDC children AS children and noted the 
clinical resemblance with Asperger’s autistic psychopath children. Those same authors, 
however, noted clear distinctions between the two conditions because children with 
SPDC lacked the repetitiveness that is a characteristic sign in autistic children had and 
the SPDC children were poorly motivated for tasks of cognition and memory. Later, 
Wolff & McGuire (1995) found that many of these children did indeed meet the criteria 
for AS.  
Kurt Schneider proposed certain symptoms that have special diagnostic importance 
for SCH in 1958 (Schneider, 1958). Schneider referred to these symptoms as “first rank 
symptoms”. These symptoms are “thought echo”, “third-person hallucinatory voices”, 
“running commentary hallucinatory voices”, “somatic passivity”, “thought withdrawal”, 
“thought insertion”, “thought broadcasting”, “made affect”, “made impulse”, “made 
volition” and “delusional perception”. Schneider stated that these symptoms are not 
always present, but when they are and there is no evidence of organic brain disease, 
then the diagnosis of SCH is verified. Later the classification value of these symptoms 
was criticized because many other disorders share these same symptoms (O'Grady, 
1990; Wing & Nixon, 1975). If these symptoms had been specific to SCH, then they 
would still be a valuable aid for diagnosis. Schneiders’ first rank symptoms are not 
typical for patients described by either Kanner or by Asperger.  
SCH and autism have been regarded as separate conditions from the 1970s onwards. 
Kolvin and colleagues (1971a) postulated that SCH in children had to be differentiated 
from autistic disorders. Rutter also concluded in 1972 that a disorder similar to that of 
adult SCH may begin in childhood (Rutter, 1972). Autism was described as a subgroup 
of SCH, infantile psychosis in ICD-8 published in 1967 and ICD-9 published in 1978. 
Term PDD was first used in DSM-III (APA, 1980). Since the publication of DSM-III, 
children with SCH have been diagnosed according to the same criteria as adults. PDD 
was entered into the ICD-classification in 1993 in (ICD-10) for the first time. Autism 
spectrum disorder is now used as a new umbrella term in DSM-5 (American Psychiatric 
Association, 2013) under neurodevelopmental disorders and SCH continues to remain 
under schizophrenia spectrum.  
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Despite of the fact that these two conditions are separate entities, they share many 
overlapping symptoms. Both disorders share some neurocognitive deficits and negative 
symptoms and there is a continuum and spectrum in both disorders. However, positive 
symptoms are typical of patients with SCH but not of patients with PDD. There has 
again been the question about the distinction between these disorders during the recent 
past (Lugnegård et al., 2011; Rapoport et al., 2009). 
 
1.4 Overlap in genetic and neuroimaging studies and clinical 
symptoms  
1.4.1 Genetic studies 
There is evidence that both SCH and PDD disorders are highly genetically determined, 
though the genetic background to PDD is heterogeneous (Kim & Leventhal, 2015) as is 
that of SCH (Rapoport et al., 2012). Candidate genes are not diagnosis-specific, 
however (Rapoport et al., 2005).  
Genetic studies show some overlap between PDD and SCH (Rapoport et al., 2009). 
For example, 22q11.2 deletion syndrome, microdeletion and microduplication in the 
16p11.2 region, disruption in gene DISC-1 (Raja & Azzoni, 2010) and missense 
mutations in Neurexin 1 (Voineskos et al., 2011) have been reported in both disorders.   	  
1.4.2 Neuroimaging studies 
Symptoms of PDD are often noticed earlier than those of COS, thus there are more 
studies of early brain development in PDD children compared with their COS 
counterparts. A common finding in PDD is that during the first years of life there is 
brain overgrowth and exaggerated gray and white matter volumes (Baribeau & 
Anagnostou, 2013). However, there is also evidence that upon structural magnetic 
resonance imaging (MRI) male infants with a high risk of developing SCH have larger 
brain volumes during the first months of their lives than normal male infant controls 
(Gilmore et al., 2010).  
Both COS and PDD seem to manifest some decrease in white matter integrity in the 
corpus callossum and cingulum compared to controls (Baribeau & Anagnostou, 2013). 
Both conditions share also abnormalities in subcortical networks, which are opposite 
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types. For instance, deficits in local connectivity but with increased long-range 
connectivity have been proposed for SCH (Baribeau & Anagnostou, 2013) whereas in 
PDD long distance under-connectivity and local over-connectivity of the frontal cortex 
have been reported (Geschwind & Levitt, 2007; Vissers et al., 2012). 
1.4.3 Clinical symptoms  
Patients with PDD often show symptoms such as anhedonia, restricted facial 
expressions, poor use of gestures, alogia, poor social relatedness or presence of 
stereotypic behavior, all resembling negative symptoms in SCH (Ghaziuddin, 2005). 
Symptoms resembling positive symptoms of SCH are also seen in high-functioning 
PDD, such as elaborate fantasies or disorganized thinking (Ghaziuddin et al., 1995). 
There is no clear consensus on how the schizophrenic symptoms might qualitatively 
differ from those described for PDD (Hallerbäck et al., 2012; Raja & Azzoni, 2009; 
Raja & Azzoni, 2010).  
 
1.5 Previously reported comorbidity  
1.5.1 PDD in patients with SCH 
It is reported that in COS, 30–50% of patients have comorbid PDD preceding the 
psychotic symptoms (Rapoport et al., 2009). According to results of a Diagnostic 
Interview for Social and Communication Disorders (DISCO-11) given to parents nearly 
half of the adults who had schizophrenic psychosis in young adulthood also had 
comorbid PDD (Hallerbäck et al., 2012). In the study by Sporn et al. (2004) 25% 
(19/75) of COS patients had a lifetime diagnosis of PDD. One of the COS patients met 
the criteria for autism, two for AS and 16 for PDD. It has also been pointed out that 
COS can be misdiagnosed because of its rarity. A study of 71 children and adolescents 
referred with history of childhood-onset psychosis, reported that only 19 referrals were 
diagnosed with SCH and six with PDD (McKenna et al., 1994). The author is not aware 
of studies concerning the prevalence of PDD in EOS-populations.  
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1.5.2 SCH in patients with PDD 
Hans Asperger (1944) reported that among his 200 AS patients only one developed 
SCH. A recent Finnish combined community-and clinic-based sample of 50 adolescents 
with AS/HFA, found that none of the adolescents had SCH or related disorders (Mattila 
et al., 2010). Psychotic disorders are uncommon in young adults with AS (Lugnegård et 
al., 2011). This also seems to be true for the entire group of PDD patients, as was 
reported in the recent review there where only occasional cases of SCH in children and 
adults with PDD (Skokauskas & Gallagher, 2010). It is reported that in adults with 
PDD, 0–3% of patients have comorbid SCH (Abdallah et al., 2011; Hutton et al., 2008; 
Stahlberg et al., 2004).  
Young adults with AS are at high risk of depression and anxiety disorders 
(Lugnegård et al., 2011). Ghaziuddin et al. (1995) studied eight children with PDD who 
were referred to them with psychotic symptoms. Those authors reported that SCH was 
suspected in only one child but was not confirmed and four other children had major 
depression diagnoses. Children with higher-functioning PDD can be especially 
mistaken as having a diagnosis of SCH instead of depression. In a recent cohort study 
(Sullivan et al., 2013) children with ASD and high-autistic trait scores were more likely 
to have psychotic experiences that associated strongly with depressive symptoms. It 
seems that it is much more common that patients with primary SCH will have comorbid 
PDD than will patients who have primary PDD and SCH as the comorbidity. 
It is also suggested that there is subtype in PDD called Multiple Complex 
Developmental Disorder (MCDD), which is characterized by early childhood-onset 
affected dysregulation, high levels of anxiety, social impairment and thought disorder 
(Sprong et al., 2008). These children do not suffer from autism or SCH, but they do 
share certain symptoms with both disorders.  
 
1.6 Catatonia  
Catatonia was first coined by Karl Kahlbaum in 1874 (Kahlbaum, 1973). He described 
25 patients with symptoms that included a wide range of motor abnormalities, 
“cataleptiform waxy flexibility” and echolalia or echopraxia. His patients often had 
affective disorders, cycles or stages of depression or mania. Emil Kraepelin cited 
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catatonia in 1893 as a main feature in “dementia praecox”, which was later became 
called SCH. Catatonia has been associated with SCH since then. The term has 
undergone changes in definitions and implications since it was first used by Kraepelin.  
In earlier classifications both the duration and the number of symptoms required for 
diagnosis have varied. There have been at least six different rating scales for catatonia, 
which were: Modified Rogers Scales, Rogers Catatonia Scale, Bush-Francis Catatonia 
Rating scale, Northoff Catatonia Rating Scale, Braunig Catatonia Rating Scale and 
Kanner scale. Each of those scales was validated in different patient populations and 
with different items included (Sienaert et al., 2011). 
Symptoms and signs that are often listed for catatonia clearly describe the motor and 
mood dysregulation aspects of this syndrome and these are: motor signs such as stupor, 
mutism, negativism, grimacing. Other symptoms and signs include impulsive acts, 
stereotypies and echopraxia/echolalia and withdrawal (Barnes et al., 1986; Bräunig et 
al., 1998; Rosebush et al., 1990; Taylor & Abrams, 1977). Catatonic symptoms are said 
to be unspecific (Taylor & Abrams, 1977) and quite common in acutely ill psychiatric 
patients (Banerjee & Sharma, 1995). The etiology of this disorder remains unknown. 
Effective treatments are electroconvulsive therapy (ECT) and medication (neuroleptic 
and benzodiazepine; Fink, 2013).  
Catatonia as defined in DSM-IV remained associated with SCH (see Table 4), but it 
also appears in a separate class as “catatonic disorder due to a general medical 
condition” (American Psychiatric Association, 1994). Catatonia defined in ICD-10 is 
included in SCH and organic catatonic disorder (WHO, 1992). Recent research has 
shown that catatonia was found in up to 10% of people with an acute psychiatric 
disorder. Only quarter of them had psychotic disorder and nearly half of them had a 
mood disorder (Rosebush & Mazurek, 2010).  
There has been a major change in the classification of catatonia in DSM-5 (Table 4), 
because catatonia has been separated from SCH and described as a disorder of its own. 
Catatonia can be associated with other mental disorders, or it can emerge within another 
medical condition, or it can remain unspecific (American Psychiatric Association, 
2013).  
Studies on adult patients with SCH-related and mood disorders have reported the 
incidence of catatonia that varied between 10–38% (Banerjee & Sharma, 1995; Bräunig 
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et al., 1998; Taylor & Abrams, 1977). Catatonia also occurs among children and 
adolescents (Cohen et al., 1999), but there are few studies on this age group. Estimated 
prevalence in young people is lower than in adults, and ranges between 0.6% and 17% 
(Cornic et al., 2007). General catatonia symptomatology and underlying disorders are 
similar in children, adolescents and adults. Incontinence was not reported in adult 
studies, but is frequently reported in children and adolescents with catatonia (Cornic et 
al., 2007).  
In the study conducted by Green and colleagues (1992), 31.6% (12/38) of 38 
hospitalized children with schizophrenic disorder showed catatonic features. Another 
study assessed all the hospitalized adolescent patients during the period of 1991 to 1997 
for catatonic signs and found only 0.6% (n = 9) of them fulfilled the criteria of catatonia 
(Cohen et al., 1999). Six of these adolescent patients had a history of SCH and another 
two patients had PDD. Elsewhere it was reported that 17.7% (11/62) of the children and 
adolescents who suffered from affective and non-affective psychotic disorders showed 
at least two signs of catatonia (Thakur et al., 2003). A recent study by Ghaziuddin and 
colleagues (2012) reported that 17.8% (18/101) of the adolescents who were diagnosed 
with disorders with known risk for catatonia, such as PDD, psychosis-Not otherwise 
specified (NOS) intermittent explosive disorder, mental retardation or neuroleptic 
malignant syndrome manifested three or more symptoms of catatonia.  
Besides the clinical diagnosis of catatonia, a wide range of chronic, less severe, and 
sometimes very subtle symptoms of posture, movement, speech, and behavior are 
considered to be catatonic in nature (Fink, 2013; Wing & Shah, 2006). The term 
“catatonia spectrum” is used to cover the whole range of these manifestations (Fink, 
2013).  
1.6.1 Catatonia and PDD 
Catatonic features have also been related to PDDs (Dhossche et al., 2010; Mazzone et 
al., 2014). Behavioral features such as motor stereotypies, mannerism, rituals, mutism, 
echolalia and negativism are described in both catatonia and ASD. Wing and Shah 
(2000) found that those individuals with ASD who have impaired language and 
passivity in social interaction are more likely to have catatonic features. Autism 
spectrum disorder as defined in DSM-5 can be specified with catatonia, which provides 
some support for the association between these two disorders.  
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Two systematic studies investigated the prevalence of catatonia in ASD. A 
prospective population-based follow-up study of 120 individuals with autism reported 
that approximately 12% of the autistic persons met the criteria for catatonia during or 
after their adolescence (Billstedt et al., 2005). Similar results were shown by Wing and 
Shah (2000). None of their patients met the criteria for full syndrome of catatonia before 
15 years of age. A total of 30 individuals (6%) of the 506 children and adults with ASD 
met the criteria for catatonia. All those individuals who met criteria for catatonia were 
over 15 years of age, thus they represented 17% (30/175) of all referrals for the >15 
years age group (Wing & Shah, 2000). Lower rates of catatonia were seen in the follow-
up study where 135 individuals with PDD were evaluated by through their responses to 
questionnaires, which indicated that 16% (21/135) participants had a psychiatric 
disorder, but only five patients had a comorbid obsessive-compulsive disorder and/or 
catatonia (Hutton et al., 2008).  
Catatonic symptoms in PDD are often preceded by stressful life events (Hare & 
Malone, 2004; Wing & Shah, 2000). Catatonic symptoms, typical for autism, are 
slowness, difficulty in initiating movements, increased passivity, amotivation and a 
worsening of ritualistic and repetitive behaviors (Wing & Shah, 2000). Wing and Shah 
(2006) also studied catatonia-like features in 200 children and adults with ASD, which 
is a broad equivalent of PDDs. They found that most of the study participants had 
displayed some catatonic features during their lifetime. These features occurred in more 
than 150 of the participants and were: a lack of facial expression, delayed echolalia, odd 
intonation, poor eye contact, and lack of cooperation.  
It was proposed that catatonia in the context of autism would be better described by 
the term “autistic catatonia” (Hare & Malone, 2004). Some forms of autistic catatonia 
might reflect a person’s extreme adaptations to environmental factors such as an escape 
from contingent demands. Underlying processes of autistic catatonia could be 
conceptualized from the same psychological processes that underlie other aspects of 
autistic behavior. For example, the lack of a central coherence model in this instance 
could lead to the inability to integrate discrete “bits” of both sensory data and motor 
action and it could lead to very slow responses and impairments in voluntary behavior.   
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1.7 Delays in developmental skills 
1.7.1 Delays in development in SCH 
A wide range of developmental delays for different domains, especially in motor, 
language, and behavior has been reported in children destined to develop SCH in later 
life. Walker and Lewine (1990) analysed childhood home movies of five AOS patients, 
and reported that they exhibited less responsiveness, eye contact and positive affect in 
addition to more problems in fine and gross motor co-ordination compared to their 
healthy siblings.  
Developmental delays reported by several birth-cohort studies are reported among 
those children who subsequently developed SCH as adults. Speech problems and delays 
in milestones of motor development, especially in walking, were reported more often in 
children who later develop SCH than other children (Jones et al., 1994). A preference 
for solitary play at the ages of four to six was also associated with later SCH. It was 
reported that at the age of seven those children who later developed SCH had more 
social maladjustment than their controls. Among boys overreactivity, hostility and 
inconsequential behavior at age seven was common. Among girls it was noted that by 
the age of 11 they had become noticeably withdrawn compared to their age matched 
peers (Done et al., 1994). Another birth-cohort study reported there were delays in 
learning to stand, walk and become potty-trained among those children who later 
developed SCH compared to their healthy peers (Isohanni et al., 2000). Cannon and 
colleagues (2002) reported that adult patients suffering from SCH had learned to walk at 
a later age and managed worse in standard motor skills at the ages three, five and nine 
than did healthy controls. Receptive language development impairments were also 
related to SCH. Internalizing problems and peer rejection occurred more often among 
children aged five to 11 who later developed SCH than among healthy individuals. 
Moreover, 2% (13/789) of 11 year-old children reported psychotic symptoms. Those 
who had strong early psychotic symptoms had more problems in neuromotor 
development, receptive language, intelligence and emotional development than those 
who had no early psychotic symptoms or weak early psychotic symptoms (Cannon et 
al., 2002). There were deficits in overall academic achievements reported among those 
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who later develop SCH compared to controls, but the differences were quite small and 
statistically non-significant (Dickson et al., 2012). 
Those children who develop COS or EOS are suggested to have more severe 
problems in language and motor development and more insidious onset of symptoms 
than in AOS (Alaghband-Rad et al., 1995; Vourdas et al., 2003). A cohort of 33 
children who developed SCH between 5-15 years of age were investigated and it was 
found that 49% (16/33) had major milestone delays and 87% (29/33) premorbid 
abnormalities (Kolvin et al., 1971b). That study found that six out of 32 (19%) parents 
of children with SCH also had SCH and thus the prevalence of SCH was relatively high 
among the parents of children with SCH (Kolvin et al., 1971c).  
1.7.2 Delays in development in PDD  
A majority of parents whose child later manifested PDD reported their concern about 
the lack of progress in their child’s development when the infant reaches the age 19 to 
24 months. The mean age at which parental concern was expressed was lower at a mean 
of 15 months for parents of mentally retarded children compared to 22 months for 
parents of a non-retarded PDD child (De Giacomo & Fombonne, 1998). According to 
Howlin and Asgharian (1999) parents of children with a diagnosis of autism were aware 
of developmental problems by 18 months of age and parents of a child with AS were 
aware of developmental problems at around 30 months of age. Some parents reported 
concern about their autistic child’s development as early as during the child’s first year 
of life (Gillberg et al., 1990).  
Deficits in reciprocal social interaction and routines are essential features for 
diagnosis of PDDs according to ICD-10 (WHO, 1992) and DSM-IV (American 
Psychiatric Association, 1994). In childhood autism abnormal or impaired development 
is evident before the age of three years thus self-help skills, adaptive behavior and 
curiosity about the environment during the first three years should be at a level 
consistent with normal intellectual development in AS children. It is also mentioned that 
motor-skills milestones may be somewhat delayed and motor clumsiness is usual 
(although not required for diagnosis). Sensory deficits were added to diagnostic criteria 
for Autism spectrum disorders in DSM-5 (American Psychiatric Association, 2013).   
 Most studies compare groups of children with developmental delay, because a 
deficit is considered to be a core for PDD when it distinguishes children with PDD from 
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those children with other atypical developmental delay. Social deficits, especially early 
joint attention deficits are relatively unique for PDD (Ventola, 2007; Wetherby et al., 
2007). Compared to other developmental delays, social problems, such as response to 
hearing one’s name, expression of affect and reduced use of gaze, using fewer 
communicative gestures are more prevalent in PDD children by the age 18 months 
(Mitchell et al., 2011).  
Problems in language development are often the first focus of parental concern (De 
Giacomo & Fombonne, 1998). Children diagnosed with PDD may learn their first word 
late (Matson et al., 2010b). Emergences of receptive communication deficits are 
common by the age of 24 months (Landa & Garrett-Mayer, 2006; Paul et al., 2014).  
Both gross and fine motor skills have been found to be more impaired in young 
children with PDD than in those children with atypical development or who have 
developmental delay due to other etiologies (Landa & Garrett-Mayer, 2006; Matson et 
al., 2010a; Provost et al., 2007). An analysis of home video recordings children with 
ASD aged between four to six months showed that delays in rolling over, sitting, 
crawling and walking skills (Teitelbaum et al., 1998).  
Children with PDD differ from those children with other developmental delay before 
the age of two as they have more impaired daily living skills, in addition to self-help 
skills such as bathing, feeding and dressing (Paul et al., 2014). Significant discrepancy 
between overall cognitive ability and adaptive functioning favoring IQ over real-life 
skills is typical in PDD (Bölte & Poustka, 2002).  
Children with AS may experience specific challenges to learning academic skills 
such as reading and spelling (Gross, 1994). Having PDD predicts that an individual is 
prone to problems in reading comprehension (Brown et al., 2013). Non-retarded PDD 
children show discrepancies between actual academic achievement levels and the levels 
predicted by their intellectual ability. It is also been suggested that improved social 
abilities may contribute to academic achievement (Estes et al., 2011). 
We are not aware of any published studies in which a direct comparison of 
developmental delays in patients with SCH and PDD has been conducted. 
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1.8 Neurocognition  
Neurocognition is a general term that covers many processes involved in human 
information processing, such as attention, memory, language skills and executive 
functions (Lezak, 1995). Deficits in neurocognition are common amongst different 
disorders.  
1.8.1 Neurocognition in SCH 
Cognitive deficits become evident many years before the onset of SCH. A prospective 
birth cohort study reported neuropsychological functioning at the age of 13 years in 
subjects at risk for developing SCH-related disorder by the age 26 (Cannon et al., 
2006). Adolescents who later developed schizophreniform disorder had more 
impairment in attention and executive functions than adolescents with mood, and 
anxiety disorders when each group was compared to its respective healthy controls 
(Cannon et al., 2006). Another study reported that deficits in verbal memory, gross 
motor skills, and attention at the ages of seven to 12 years distinguished those who 
develop SCH-related psychoses in adulthood from those who did not among subjects at 
risk of SCH (Erlenmeyer-Kimling et al., 2000). Deficits in processing speed have been 
reported in young individuals who later developed SCH, compared to healthy controls 
and unaffected siblings (Niendam et al., 2003; Sørensen et al., 2006). 
Deficits in memory are wide-ranging and consistently present in patients with SCH 
(Aleman & Hijman, 1999). Deficits in working memory (Silver et al., 2003) and 
declarative memory (Heinrichs & Zakzanis, 1998), slower processing speed (Dickinson 
et al., 2007) and impairments in executive functioning (Liu et al., 2011) are typical 
neurocognitive findings in adult SCH patients. A recent, longitudinal study by 
Dickerson and colleagues (2014) reported that there was no decline in cognitive 
functions during the 10-year follow-up period for middle-aged persons with SCH. In 
contrast a 10-year follow-up study by Stirling and colleagues (2003) concluded that 
visuo-spatial function may deteriorate over time but executive functions deficits do not 
deteriorate further.  
There are deficits in attention (Frangou et al., 2007; McClellan et al., 2004), verbal 
memory (Frangou et al., 2007; Øie et al., 1999), visual memory (Øie et al., 1999) and 
executive functions (Kravariti et al., 2003) for EOS those are similar to those described 
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for AOS. Overall profiles in neurocognitive functions are said to be similar in EOS and 
AOS (Rhinewine et al., 2005). Longitudinal studies of EOS reveal deficits in most of 
the cognitive functions appear quite stable over the years (Frangou et al., 2007; Juuhl-
Langseth et al., 2014). Immediate verbal memory and attention may show deterioration 
during the years, but speed of information processing may show an improvement 
suggesting aspects of normal brain-maturation in these patients (Frangou et al., 2007). 
The opposite findings have also been reported. A longitudinal study over a period of 
13 years compared patients with EOS, against ADHD and a control group (Øie et al., 
2010). That study found deteriorations, in verbal memory, learning, attention and 
processing speeds the profile of which was unique to the SCH group. One explanation 
for this result was that the decline was specific for EOS due to the interaction between 
ongoing brain maturation during adolescence and disease-related mechanisms. It may 
also be secondary to neuroleptic treatment and/or to limited social stimulation.  
1.8.2 Neurocognition in PDD 
The neurocognitive deficits most often described for PDDs include deficits in weak 
central coherence and executive functions. Weak central coherence refers to processing 
bias that occurs as result of the subject focusing on details, specific features and local 
information instead of processing the global meaning (Frith, 1989). A person with a 
PDD often fails to see the “big-picture”: instead they focus only on details. Weak 
central coherence is also proposed to affect the ability to give global, contextually-
appropriate answers to open-ended sentences (Happé, 1994) and to recognize facial 
emotions (Happé & Frith, 2006).  
Executive functions refer to a wide range of mental skills, and can be described as 
the “ability to maintain an appropriate problem-solving set for the attainment of a future 
goal” (Pennington & Ozonoff, 1996). Deficits in flexibility, fluency and response 
selection/monitoring are especially common in PDDs (Happé et al., 2006; Kleinhans et 
al., 2005). Deficits in inhibition, planning and self-monitoring are also often reported  
(Robinson et al., 2009). 
Visual processing, however, is often relatively intact (Ghaziuddin & Mountain-
Kimchi, 2004; Joseph et al., 2009; Kaufman, 1994; Minshew et al., 1997; Samson et al., 
2012; Williams et al., 2006). Specific difficulties in using vision among those with PDD 
have been reported, but contradictory results have also been published (Simmons et al., 
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2009). Minshew et al. (1997) studied neuropsychological functioning of 33 non-
retarded adolescents and young adults with PDD. Those authors reported significant 
impairments of motor skills, complex language, complex memory and reasoning 
domains, but they also reported intact or superior performance for the attention, simple 
memory, simple language and visual-spatial domains. Williams and colleagues (2006) 
replicated the study with 56 non-retarded children with PDD. Both studies included 
matched control groups (Minschew et al., 1997; Williams et al., 2006). Results from 
both studies provided evidence that non-retarded PDD patients are characterized by 
selective impairment in higher-order abilities but had intact simpler basic abilities in 
these same domains.  
1.8.3 Comparisons of neurocognition between SCH and PDD 
Only a few comparison studies have focused on neurocognition in children and 
adolescent populations despite the many overlapping symptoms in SCH and PDDs. A 
study by Asarnow and colleagues (1987) compared cognitive functioning as measured 
by Wechsler Intelligence Scale for Children (WISC) between 23 autistic children (21 
male and two female) with a mean age of 10.4 years (SD = 2.4) and 24 SCH children 
(17 male and 6 female) with mean age 10.1 years (SD = 1.8) with normal intelligence.  
Children with autism scored significantly lower on the Comprehension subtest than did 
children who had SCH, but children with SCH showed significantly lower scores on the 
Block Design, Object Assembly, Coding and Arithmetic subtests.  
Schneider and Asarnow (1987) studied 15 children with PDD (14 male and 1 
female), 11 children with SCH (8 male and 3 female) and 28 normal controls (22 male 
and 6 female), all participants had normal intelligence. Ages of the children varied 
between seven years 10 months and 14 years four months. They reported that the 
children with PDDs and those with SCH had similar problems in processing speed and 
executive functions. These authors also reported that PDD and SCH group 
performances in the Wechsler Coding subtest and visual search, as measured by Rey’s 
Tangled Line Test were poor for both groups. Neither group showed impairment in 
visuospatial functions. Wechsler Coding subtest and visual search and Rey’s Tangled 
Line Test, both require sustained attention and visuo-motor co-ordination. Children with 
PDDs showed significantly more impairment in verbal functioning than did those with 
SCH.  
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Bölte and colleagues (2002) used the WISC-III (Wechsler, 1991) and Wechsler 
Adult Intelligence Scale third edition (WAIS-III; Wechsler, 1997) to study adolescents 
with PDD or with SCH. The mean age was 16.8 years for the PDD group and 16.6 years 
(SD = 1.5) for the SCH group. Both groups consisted of 11 male and nine female 
individuals of whom 13 in both groups had IQ scores of over 70. There was no control 
group in this study. The patient groups showed no significant differences on any single 
Wechsler subscale, but the pattern of performance profiles seemed to differ between 
groups. For example, the PDD group showed peak performance for the Object 
Assembly, Similarities, and Information subtests, but had the lowest scores on the 
Picture Arrangement subtest, Digit Symbol and Comprehension. The SCH group on the 
other hand showed a more even pattern between the subtests, and scored highest on the 
Object Assembly and Digit Span subtests, and lowest on the Picture Arrangement and 
Digit Symbol (Coding) subtests. The largest differences between these two groups were 
in Comprehension and Similarities.  
These comparisons show that there are differences in cognitive profiles between 
SCH and PDD. Findings suggest that children and adolescents with SCH may be 
relatively more impaired at visual processing than those with PDDs, whereas children 
and adolescents with PDDs may be relatively more impaired at higher order verbal 
processing. Adolescents with SCH may have more general neurocognitive difficulties, 
whereas adolescents with PDD have selective impairment of higher-order abilities.  
 
1.9 Social cognition  
Social cognition is an umbrella term for processes that make social interaction possible 
between individuals of the same species (Frith & Frith, 2007). Theory of mind (ToM) 
and emotional processing are functions that belonging to social cognition. Social 
perception and knowledge and attribution bias are related functions under the term 
social cognition (Green, 2008).  
In study IV, we compared ToM and affect recognition components of social 
cognition that are quite widely studied among these patient groups.  
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1.9.1 Theory of Mind 
The theory of mind (ToM), or mentalizing, is the ability of a person to predict and 
explain the behavior of other humans in terms of their mental states. It was first 
described by Premack and Woodruff (1978). ToM can be seen as a sum of many 
developmental skills that are essential to understand another’s mind. For example, 
understanding the causes of emotions, deception and understanding metaphor and 
sarcasm (Baron-Cohen, 1998). Joint attention, imitation, the ability to track a speaker’s 
intention during learning and decoding of words and pretend-play are also a part of the 
ToM system (Korkmaz, 2011).  
ToM is a developmental skill that fully develops only in human beings (Korkmaz, 
2011). A child whose development is normal begins simultaneously to take into account 
the real situation and the pretend version of the same situation at the age 18–24 months. 
Until three-years age a child normally learns to use semantic terms for mental states that 
include others (know, think, and pretend). A four-year old child understands that beliefs 
and desires are private and changeable and do not depend on an external state of reality 
changing. Normal children will pass the first-order ToM test at three to four years of 
age. Second-order tasks in which a person needs to understand what two people think 
sequentially can usually be passed by normal children at the age six-years.  
1.9.2 Deficits in ToM in SCH  
Frith (1994) posited that many clinical symptoms and signs such as delusions, auditory 
hallucinations and negative symptoms, observed in patients with SCH could be 
attributed to problems in ToM. There is currently no consensus on whether problems 
observed in social cognition are the result of neurodevelopmental impairment or 
neurodegenerative process in SCH however (Ozguven et al., 2010).  
ToM problems are widely reported in SCH, such as in first-degree unaffected 
relatives of SCH patients (Bora & Pantelis, 2013), first-episode patients in the early 
stage of SCH (Bora & Pantelis, 2013; Koelkebeck et al., 2010), chronic patients, and 
also those patients in the remission phase of the illness (Bora et al., 2009; Sprong et al., 
2007). 
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1.9.3 Deficits in ToM in PDD 
Impairments in ToM were first related to autism by Baron-Cohen and colleagues 
(1985). They found out that 80% (16/20) of autistic children failed to predict correctly 
beliefs of others, whereas 85% (23/27) of normal children and 86% (12/14) of children 
with Down’s syndrome were able to do so. Deficits in ToM have been proposed to be a 
core deficit in PDD.  
Both first-order and second-order ToM tasks can be easy for people with higher-
functioning PDDs, whereas more advanced tasks tend to be problematical (Bowler, 
1992; Ozonoff et al., 1991). It is argued that individuals with PDD may learn ToM 
skills explicitly, but not implicitly. Often social problems are more evident in real life, 
than in test situations. An individual with PDD has time to react in a test situation, but 
in real life situation quick responses are required and that causes problems in ToM 
testing (Frith, 2004). 
1.9.4 Comparisons of ToM in SCH and PDD 
Only a few studies have compared ToM performance of children and adolescents with 
SCH and PDD. A study by Pilowsky and colleagues (2000) compared the ToM 
performance of children and adolescents with HFA to the ToM performance of those 
with SCH. The study also found that 58% (7/12) of youngsters with autism and 67% 
(8/12) of those with SCH passed the “false belief task”, which was considered the most 
demanding one. Moreover, patients with SCH performed better at the deception task 
than those with autism, whereas no difference was found between SCH and PDD 
groups in other ToM tasks. 
Of investigations on adults, the study by Lugnegård and others (2013) included 89 
adult patients with SCH or AS and a non-clinical control group. Overall, the SCH group 
had similar problems in the ToM tests as the AS group. Adult patients with AS or with 
SCH performed poorly in ToM tests and also in other studies compared to healthy 
controls (Chung et al., 2014; Craig et al., 2004; Murphy, 2006). However, Ozguven and 
others (2010) reported that in general, adult patients with AS had worse ToM 
performance scores than patients with SCH. Their results showed that SCH patients had 
impaired second-order, but unimpaired first-order ToM performance. There is, however, 
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a wide range in the performance of AS patients as some performing better than others in 
the ToM test (Murphy, 2006).  
There is also considerable heterogeneity in the test methods used to assess ToM. All 
previously mentioned studies used different assessment tools for ToM testing, some of 
them used verbal tests only. There is currently no consensus on the optimum battery of 
test for ToM, which may reflect the fact that the definition of ToM is quite broad.  
1.9.5 Facial affect recognition 
Facial affect recognition is the ability to recognize and discriminate between emotions 
in the facial expressions of others (Ekman, 1972). This ability is important for 
successful interaction with others and to participate actively in the social environment 
(Morris et al., 2009). It is also vital for the development of the perceptual components 
of ToM (Korkmaz, 2011). Furthermore, affect recognition can also be based on the 
evaluation of gestures or vocalization.  
1.9.6 Deficits in affect recognition in SCH  
Impaired facial affect recognition is a prominent feature in SCH (Kohler et al., 2000; 
Morris et al., 2009) and some have suggested that this deficit could be a trait marker, 
since it also occurs in first-episode psychosis (Edwards et al., 2001). There are only a 
few studies about affect recognition deficits in SCH children and adolescents in 
existence. Both children and adults with SCH have showed deficits in affect recognition 
compared to healthy controls (Habel et al., 2006; Seiferth et al., 2009).  
1.9.7 Deficits in affect recognition in PDD 
Deficits in facial affect recognition were investigated in retarded autistic children 
(Hobson, 1986). Children with autism in that study had significant problems selecting 
the appropriate facial expression to match gestures, vocalizations and emotional 
contexts. Recently Wright et al. (2008) reported that emotion recognition may be 
undisturbed in patients with higher functioning PDDs. A recent review article suggested 
that mixed results in facial emotion recognition studies among PDDs could have 
resulted from a compensatory mechanism such as verbal mediation or feature-based 
learning, which individuals with PDD can use. Another explanation is that deficits in 
facial emotion recognition in high-functioning individuals do emerge but only when 
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facial-emotion processing is ambiguous (Harms et al., 2010; Kuusikko et al., 2009). In 
their study Kuusikko et al. (2009) found that while in upper-facial basic emotion 
recognition the ASD group scored lower than the controls, the older ASD group 
performed better than the younger ASD group.  
1.9.8 Comparisons of affect recognition in SCH and PDD 
Children with autism exhibit significantly more problems in interpreting emotional 
meanings in speech than do those with SCH (Van Lancker et al., 1989). Another study 
(Bölte & Poustka, 2003) also explored differences in facial affect recognition between 
SCH and PDD. Again, adolescents diagnosed with autism performed significantly 
worse than did those with SCH.  
Results of affect recognition in SCH and PDD patients are more consistent in adults 
and both groups seem to share some deficits. Thirty adult patients with diagnosed 
autism or SCH were studied (Sasson et al., 2007) and it was found that both clinical 
groups had more abnormalities in visual scanning in social situations compared to a 
control group (Sasson et al., 2007). In a large study of 80 adult male patients, those with 
SCH or HFA were compared to a control group (Couture, 2010). Both the SCH group 
and the HFA group had more problems in social cognition tasks compared to the 
controls, but the clinical groups did not differ from each other. Four different 
dimensions were used for the evaluation. Two dimensions measured emotion 
perception, one social judgment and one ToM. When the SCH group was divided into 
subgroups the SCH group with negative symptoms had more similarities in their 
performance with the AS group compared to the group with positive symptoms 
(Couture, 2010).  
These findings suggest that emotion detection deficits could be part of the 
endophenotype of autism. It also seems that though social cognition in SCH is less 
impaired than in autism, it is not intact. 
	   45 
Although neurocognition and social cognition are separate domains of cognition, 
they are closely related (Sergi et al., 2007). Poor neurocognition usually predicts 
problems in social cognition, but it is also common for a person to have deficits in 
social cognition and also have intact neurocognition (Fanning, et al., 2012). However, 
facial emotion recognitions and expressions in addition to executive functions are 
essential for development of ToM (Korkmaz, 2011). Social cognition in SCH typically 
associate more strongly with poor community functioning, including problems in 
independent living and social or work functioning when compared to problems in 
neurocognition (Fett et al., 2011).  
These two disorders seem to co-occur and share many common features, therefore 
we made a comprehensive study about development and what features these conditions 
share with each other and what features differ. We are not aware of any previous 
published studies on adolescents with SCH and comorbid PDD.  
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2 AIMS OF THE STUDY 
 
2.1 The main aims of the thesis 
This research investigated adolescent SCH patients and some of these patients had 
comorbid PDD. The main aim was to investigate the comorbidity of SCH and PDD and 
the overlap of clinical and developmental symptoms. The differences between 
neuropsychological profiles across selected domains of the SCH and PDD groups were 
also studied. 
 
2.2 Specific aims of the studies 
Study I assessed whether there was comorbid PDD in adolescent patients with SCH. 
The aim was to report those concurrent clinical features that are usually referred to as 
PDD among adolescents with SCH. 
 
Study II evaluated catatonic features among adolescents with SCH and compared the 
nature and numbers of those features between adolescents suffering from SCH alone 
with those SCH patients with comorbid PDD. A comparison was also made between the 
profiles of catatonia-like features of SCH patients to those described earlier for persons 
with ASD without SCH.  
 
Study III assessed the delays in developmental skills in adolescents who were suffering 
from SCH with or without comorbid PDD. Compared the ages of SCH patients with 
PDD with those of SCH alone when their respective parents/caregivers first became 
worried about their children’s’ development. 
 
Study IV investigated neurocognition and social cognition skills (ToM and emotion 
recognition) in adolescent SCH patients with or without comorbid PDD and in 
adolescents with PDD only. Comparisons were made between all three groups. 
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3 PARTICIPANTS AND METHODS 
 
3.1 Participants with SCH (Studies I-IV) 
The data were collected from the Hospital District of Helsinki and Uusimaa, which is 
located in Southern Finland and comprises approximately 1.4 million inhabitants of 
whom ca. 82 500 were 13- to 17-year-old adolescents between the years 2009 and 2011. 
During the study period, the hospital district ran three rehabilitation units for 
adolescents with SCH. The study comprised a consecutive sample of patients (n = 18, 7 
males, 11 females) and their families from all three rehabilitation units. The mean age 
of the participants at recruitment was 15.6 years, SD 1.4 years, (range 13–17 years, 
Studies I-III). The mean age of the participants was 16.2 years (SD 1.5 years, range 
13.3–18.0 years) at the time the psychological tests (Study IV) were conducted. The 
diagnosis of SCH was based on an assessment according to the Kiddie Schedule for 
Affective Disorders and Schizophrenia (K-SADS-PL) for DSM-IV (Kaufman et al., 
1997), and was performed by a clinical psychiatrist. Four patients had COS, whereas 
among the other 14, the onset of the disorder occurred at age 13 or later in life. Of the 
18 participants, 17 scored > 70 IQ (mean 93, SD 16) in a standard psychological 
assessment (WISC-III/WAIS-III; Wechsler, 1991; Wechsler, 1997) which was 
performed during or before the study period. All participants had a primary IQ > 70 
based on life chart documents. Of the 18 SCH participants, birth records were available 
for 16, records from well-baby clinics for 15, and school health care reports for 17. One 
adolescent had suffered from epilepsy in early childhood, but was seizure-free and 
without antiepileptic medication during the study period. A non-contrast brain MRI was 
performed and evaluated by a clinical radiologist. The result was normal in all cases.   
 
3.2 Participants with PDD only (in Study IV) 
Fifteen adolescents with PDD only were recruited either from the Department of Child 
Neurology, Hospital for Children and Adolescents, Helsinki University Central Hospital 
(1 male, and 5 females), or the Department of Adolescent psychiatry, Tampere 
University Hospital (6 males and 3 females) between 2011 and 2013. They all had 
primary IQ > 70. The mean age at recruitment was 16.1 years (SD 1.6, range 13.3–
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18.0). The Autism Diagnostic interview–Revised (ADI-R; Lord et al., 1994; Rutter et 
al., 2003) or The Developmental, Dimensional and Diagnostic Interview (3di; Skuse et 
al., 2004) were used in clinical diagnostic assessment procedure. Exclusion criteria 
included a diagnosis of SCH and other severe psychiatric disorders. A psychiatrist and 
child neurologist specialized with neuropsychiatric disorders verified the diagnoses 
according to the DSM-IV (American Psychiatric Association, 1994). The patients with 
PDD only were age- (±6 months) and gender-matched with those with SCH at the time 
of psychological assessment.  
 
3.3 The Diagnostic Interview for Social and Communication 
Disorders 
The information from the Diagnostic Interview for Social and Communication 
Disorders (DISCO-11) was used in Studies I-III. Interviews with parents of all SCH 
patients were given. The DISCO version-11 is a semi-structured interview that was 
developed by Lorna Wing and Judith Gould in England (www.autism.org.uk) to be 
given to parents or to other primary caregivers (Wing, 2006). The interview takes two–
three hours and it contains 387 questions about current skills, development of these 
skills and atypical behavior (e.g. repetitive stereotyped activities, emotions, maladaptive 
behavior and psychiatric disorders and forensic problems) during the lifespan of the 
primary caregivers’ charges. In the DISCO, the average ages when a normal child is 
expected to achieve developmental steps, have been adopted from the Vineland 
Adaptive Behavior Scales (Sparrow et al., 1984). The DISCO included a question about 
the child´s age the first time that the parents/caregivers became worried about their 
child´s development. 
The DISCO is constructed for both clinical and research use to assess ASD in 
individuals of all ages and all levels of abilities. A computerized algorithm has been 
developed for assessing DISCO for research purposes. An algorithm is included for 
different diagnostic categories. We used ICD-10 criteria for assessing autism, AS, 
atypical autism onset of age and/or atypical symptoms for AS (WHO, 1992). ICD-10 
algorithm diagnoses in DISCO are equivalent to those in DSM-IV. ICD-10 Childhood 
autism is equivalent to DSM-IV Autistic disorder, ICD-10 Asperger syndrome is 
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equivalent to DSM-IV Asperger’s disorder and ICD-10 Atypical autism is equivalent to 
DSM-IV PDD-NOS. DISCO has good inter-rater reliability (Wing et al., 2002) and 
high agreement has also been shown between DISCO and ADI-R classification (Nygren 
et al., 2009).  
The interview is structured to collect information about the current situation 
(“current") in addition to information about development and previous (“ever”) 
behavior. If a rating of recent onset of atypical behavior is made according to the 
manual it cannot be indicated. The reason is that some behaviors could have been 
present for some time in the past, which would lead to bias created by double counting 
as both “ever” and “current” indicate that the behavior is present in both situations. In 
the present study an aim was to compare behavior and skills in childhood with those in 
adolescence, because PDD is already clearly present in childhood, before the onset of 
puberty. For this reason we adapted Studies I-II by splitting information into childhood- 
(“ever”) and adolescence-sections (“current”). If the behavior was present before 10-
years, it was scored “ever” and if the behavior was present at or after 10-years age it 
was scored “current”. Behavior disappearing after the age 10 was scored as “ever”. A 
similar adaptation was used by Hallerbäck et al. (2012), who scored earlier behaviors in 
childhood only as “ever” and current behavior as “current”. 
Another adaptation of the DISCO-11 was made in Study II. In the original DISCO 
manual, the items, which are present are divided into moderate or marked according to 
their severity. However, in line with the study by Wing and Shah (2006), this was not 
done in Study II. Instead each catatonic item in Study II was defined as either absent or 
present. Moreover, the catatonic features in Study II were evaluated as the following: 
lifetime features, features existing before the age of 10 (=childhood catatonic features) 
and features existing at the age of 10 or later in life (=adolescence catatonic features). 
The author (P.W.) was trained in the administration of the DISCO by the originators 
and she carried out all the interviews.  
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3.4 The Wechsler Intelligence Scale for Children -3rd version 
The WISC-III is an individually administered intelligence test for children between the 
ages of 6 and 16 (Wechsler, 1991). The test includes verbal subtests; Information, 
Similarities, Arithmetic, Vocabulary, and Comprehension and nonverbal subtests; 
Picture Completion, Coding, Picture Arrangement, Block Design, and Object 
Assembly.  
We used the following eight subtests of the test in Study IV: Information, 
Similarities, Arithmetic, Comprehension, Picture Completion, Coding B, Block Design 
and Object Assembly.  
There were missing values for three participants with SCH: for one of these 
participants the Object Assembly subtest was missing, another participant was not 
assessed by the WISC-III, the third SCH participant was assessed by the Wechsler 
Adult Intelligent Scale -3rd version (WAIS-III; Wechsler, 1997) instead of the WISC-III 
and the fourth patient who had PDD only had missing data for the Comprehension 
subtest.  
 
3.5 ToM and Affect recognition subtests in NEPSY-II 
NEPSY-II (Korkman et al., 2008; Kemp & Korkman, 2010) is a comprehensive, co-
normed, and multidomain neuropsychological battery designed for assessing 
neurocognitive abilities in 3-16 year-old children and adolescents. We used two subtests 
of the NEPSY-II for evaluating social cognition in Study IV: ToM and Affect 
recognition.  
The ToM subtest consists of two parts: one with verbal items (max. score 17), and 
the other part with contextual items (max. score 8). Assessment of the verbal items 
requires the participant to either hear verbal descriptions or see pictorial descriptions of 
social situations and then answer questions about those situations. The participants’ 
understanding of the point of view of the index character in addition to figurative 
language were evaluated. In contextual items, the participant sees pictures that depicts a 
social context and then selects a photo that shows the appropriate affect for the index 
character. The participant must recognize emotions linked to social situations and cues.    
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The affect recognition test assesses the person’s ability to recognize emotional 
expression (happiness, sadness, anger, fear, disgust, and a neutral emotional state) in 
photographs of children’s faces (max. score 45). Participants must match and recognize 
faces expressing the same feeling. One participant with SCH was unable to complete 
this test.  
 
3.6 Data Analysis  
Study I data was descriptive and was analyzed manually. The data in Studies II-IV were 
analyzed using IBM SPSS statistics for Macintosh, version 21.0. (Argyrous, 2011; IBM 
Corp., 2012).  
3.6.1 Study II 
The Mann-Whitney U-test, Likelihood ratio chi-square test, and the Fisher`s exact test 
were used to compare the groups. The Wilcoxon signed rank test for within group 
comparisons was used. The findings were considered significant when p-values < 0.05 
were obtained. The magnitude of the effect size (phi coefficient) was interpreted as 
follows: 0 to 0.10, negligible association; 0.10 to 0.20, weak association; 0.20 to 0.40, 
moderate association; 0.40 to 0.60, relatively strong association; 0.60 to 0.80, strong 
association; and 0.80 to 1.00, very strong association (Rea & Parker, 1992). 
3.6.2 Study III 
Fisher´s exact test, the Likelihood Chi Square test, Independent t-test and Mann 
Whitney U-test were used to compare the groups. The findings were considered 
significant when p < 0.05. Bonferroni correction was not used to control for type I 
errors due to the multiple comparisons, as it has been criticized for dramatically 
increasing the risk of type II errors (Moran, 2003; Nakagawa, 2004; Perneger, 1998). 
Instead, effect sizes are reported. The magnitude of the effect size was interpreted as 
follows: 0 to under 0.10, negligible association; 0.10 to under 0.20, weak association; 
0.20 to under 0.40, moderate association; 0.40 to under 0.60, relatively strong 
association; 0.60 to under 0.80, strong association; and 0.80 to 1.00, very strong 
association (Rea & Parker, 1992).  
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3.6.3 Study IV 
The published norms of the tests extend only up to the age of 16 years, thus all 
comparisons involved raw scores. Data was analyzed using permutational 
(nonparametric) MANCOVA (eg. Anderson, 2001) with gender and age as covariates. 
The results of permutational MANCOVA were further examined using individual 
permutational ANCOVA as proposed by Manly (2007). A correction for multiple 
comparisons was done using False Discovery Rate (FDR; Benjamini & Hochberg, 
1995). The post-hoc tests were carried out by doing all possible pairwise comparisons 
between groups using independent samples t-tests with FDR correction. The test 
statistics of permutation tests are calculated precisely as standard parametric tests but 
the p-values are calculated based on sample-specific permutation distribution of that 
statistic which doesn’t require any distributional assumptions. All permutational 
analyses were analyzed using R version 3.0.2 statistical environment (R Core Team, 
2013), other analyses using IBM SPSS version 21.0 (mac) (Argyrous, 2011). The 
NEPSY-II raw scores were analyzed using ANCOVA only because MANOVA is most 
powerful when the variables correlate with each other. In our sample, the NEPSY-II raw 
scores showed no significant correlation with each other. All correlations (Pearson) 
remained below 0.18. For all comparisons, effect sizes were calculated using partial eta 
squared where values around 0.02 are considered small, values around 0.13 are 
considered medium and values around 0.26 are considered large (Cohen, 1992).  
Differences in age and IQ between the three groups were tested with Kruskal-Wallis 
and the difference in gender with Chi-square test. The norms used in WISC were not 
age appropriate in all cases (norms in WISC only extend up to 16), but as the age in the 
groups was similar, the group comparison should be valid. 
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3.7 Ethics 
All SCH participants and their parents/guardians in Studies I-IV provided their written 
informed consent after receiving verbal and written information about the respective 
study. Each study plan was evaluated by the ethics committee of the Helsinki and 
Uusimaa Hospital Districts. The permissions to conduct the studies were granted by the 
pertinent institutional authorities of the Helsinki University Central Hospital and 
Hyvinkää Hospital Area. 
Tampere University Hospital also granted their permission to conduct the study with 
reference to patients with PDD only in Study IV who lived in the Tampere area.	  
	   54 
4 RESULTS 
The summary of the main results are presented by study. More detailed results are 
available in the original published articles. 
 
4.1 Study I: SCH and comorbid PDD in adolescents and current 
features in SCH that resembles symptoms in AS 
Forty-four percent (n = 8) of adolescents who suffered from SCH fulfilled the diagnosis 
of at least some PDDs in childhood. Table 5 shows that two of them had childhood 
autism (F84.0), three had atypical autism (F84.1) in childhood and three fulfilled the 
criteria for AS (F84.5). Of the three subjects that had atypical autism, two (12, 14) had 
the onset after three years of age and all three had atypical symptomatology. 
 
Table 5.  Retrospective childhood PDD diagnosis of adolescents with SCH. 
 
Subject 
number
Childhood Adolescence Childhood Adolescence Childhood Adolescence
F84.0 1 x x x x x x
Childhood 2 x x x x x x
autism
F84.1 8 x x x x
Atypical 12 x x x x x
autism 14 x x x x
F84.5 3 x x x x x
Asperger's 9 x x x x x x
disorder 15 x x x x x x
No PDD in 4 x x x x
childhood 5 x x
6 x x x
7 x x x x
10 x x x x
11 x x x x
13 x x
16 x
17 x x x x
18 x x x x
Communication
Reciprocal social 
interaction
Restricted, stereotyped, 
repetitive behavior
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None of the three subjects who fulfilled the diagnostic criteria for AS had been 
diagnosed in childhood, although in one case there was a suspicion of PDD at the age of 
10. One patient with childhood autism had got the PDD-diagnosis before the onset of 
psychotic symptoms, whereas the other patient was diagnosed with selective mutism at 
the age of six. The three subjects with atypical autism did not have PDD-diagnosis in 
childhood. 
Article I, Table 1 shows that 10 out of 18 patients fulfilled the required symptom 
criteria for AS after 10 years of age, whereas only two of them fulfilled the entire 
criteria for AS of origins in early childhood. One patient had AS in childhood and PDD 
that was unspecified after 10 years of age. Six of those patients who did not have any 
PDD in childhood fulfilled the AS criteria in adulthood. All SCH subjects in 
adolescence had one or more of the core symptoms of PDD. All participants had 
treatment with antipsychotic medicines, which in most cases involved the modern 
serotonin–dopamine antagonists (e.g. risperidone or clozapine). The mean duration of 
antipsychotic medication was 1.2 years (SD 1.2, range 0–5). There were four 
adolescents who had the onset of psychotic symptoms of SCH before or at 12 years of 
age. One of them had childhood autism, one had AS, one had atypical autism and the 
fourth adolescent had no comorbid PDD. More detailed background information is 
presented in Table 6.  
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Table 6. Background information on the adolescents with SCH with and without comorbid PDD. 
Subject number 1 2 8 12 14 3 9 15 4 5 6 7 10 11 13 16 17 18
Started school in normal 
class x x x x x x x x x x x x x x x x x x
Received special education 
in childhood x x x x x
Received speech therapy x x x x
Development of independent 
sitting was delayed x x x x x x x x x
Learned walk late x
Had poor coordination in 
childhood x x x x
Had poor coordination in 
adolescence x x x x x x x x x
F84.5 
Asperger's 
disorder
F84.0 
Childhood 
autism
F84.1 
Atypical 
autism No PDD in childhood
	  
 
4.2 Study II: Catatonic features among those adolescents with 
SCH with or without comorbid PDD 
All 18 adolescents with SCH had showed some catatonic features in their lifetimes (see 
Table 7). Fourteen of them (77.8%) had already manifested these features before the age 
of 10. The most prevalent lifetime catatonic features were “lacks facial expression”, 
“lack of cooperation”, “odd intonation”, and “poor eye contact” followed by “blank 
look in eyes” and “destructive behavior”.  
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Table 7. The 28 catatonic features evaluated in childhood, adolescents and lifetime in patients with SCH 
with or without comorbid PDD. 	  
Movement Speech and vocalization 
Eye contact Unsocial behavior Visual fascinations 
Odd gait Immediate echolalia Poor eye contact Shouts for no reason  Spins objects 
Poor coordination Delayed echolalia Sideways glances Aggressive for no reason Twists hands near eyes 
Odd hand postures Odd intonation Blank look in eyes Lack of cooperation Closely inspects objects from different angles 
Runs in circles Shrieks for no reason Stares Destructive 
Rocks while sitting  Laughs for no reason Strips in public 
Complex body movements Inappropriate personal habits 
Walks on tiptoe Hyperactive 
Grimaces 
Lacks facial expression 
Behavior 
 
The number of catatonic features increased significantly after the transition from 
childhood to adolescence (in childhood: mean 4.1, SD 4.4, median 3, range 0–14, vs. in 
adolescence: mean 8.9, SD 3.1, median 9, range 4–15; Wilcoxon rank signed test, z = -
3.249, p = 0.001). 
The childhood, adolescence and lifetime prevalence of 28 catatonic features are also 
presented in Article II Table 1.  
 
Table 8. Numbers and total numbers of different catatonic features in childhood, adolescence and lifetime 
in SCH patients with or without comorbid PDD.	  
mean SD range mean SD range Sig.
Number of catatonic 
features/person
In childhood 1.50 1.72 0–5 7.30 4.71 0–14 p=0.01
In adolescence 8.50 2.95 4–13 9.40 3.34 5–15 NS
Lifetime 8.80 2.94 4–14 11.10 3.09 6–16 NS
Amount of different 
catatonic features in 
whole group
In childhood 11 22 p  < 0.001
In adolescence 19 22 p=0.04
Lifetime 21 24 NS
Schizophrenia only Schizophrenia and 
comorbid PDD
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As seen in Table 8 the numbers of catatonic features in childhood were significantly 
higher among the patients with a comorbid PDD compared to those without one. 
Nevertheless, during adolescence and the number of catatonic features throughout the 
whole lifetime, there was no significant difference between the two groups. The 
numbers of catatonic features increased significantly among those SCH adolescents 
without a comorbid PDD during the transition from childhood to adolescence, but not 
among those with a comorbid PDD. 
Of the 28 catatonic features studied, those adolescents with SCH and a comorbid 
PDD had significantly more total features in childhood and in adolescence than those 
adolescents with SCH only. There was no significant difference between these two 
groups for the total number of lifetime features. 
Comparisons of the frequencies of 28 catatonic features between these two groups in 
childhood show five specific features seen in Article II Table 2: “lacks facial 
expression”, “delayed echolalia”, “odd intonation”, “destructive” and “strips in public” 
occurred significantly more often among the patients with a comorbid PDD. In 
adolescence there was only one catatonic feature, “grimaces”, occurred significantly 
more often among the patients with a comorbid PDD. 
 
4.3 Study III: Delays in developmental skills among those 
adolescents with SCH with and without comorbid PDD 
Delays in developmental skills of adolescent SCH patients were studied. In this study 
43 developmental items taken from 17 developmental areas (see Table 9) from DISCO-
11 were analyzed. All adolescents with SCH exhibited some developmental delays. The 
median number of skills with a delay was three for all patients. The mean age of the 
adolescents when, for the first time, their parents or guardians became worried that 
something might be wrong with their child´s development was 99.7 months (8.3 years) 
(SD 65.1, range 12–204). 
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Table 9. 17 developmental areas studied in adolescents with SCH with or without comorbid PDD. 
 
Gross%motor%skills
Toilet%training
Feeding
Dressing
Hygiene
Domestic%skills
Independence
Receptive%communication
Expressive%communication
Non>verbal%communication
Social%interaction%with%adults
Social%interaction%with%age%peers
Social%play
Imagination
Visuo>manual%and%spatial%skills
Pictures,%reading%and%writing
Cognitive%skills%and%achievements
 
 
All the delays in developmental skills are presented in Article III Table 1. The most 
frequent delays were in “reading their first book”, “independent sitting”, “riding a 
tricycle”, “cooperative play”, and “role play with their age peers”, followed by “riding a 
bicycle”, “tying their shoelaces”, “expressing meaningful words”, “spontaneously 
joining in with their age peers”, “parallel play and drawing recognizable objects or 
persons”.   
 
Table 10. The mean age of SCH children when their parents first became worried about children’s 
development and the individual numbers and totals of delayed developmental skills of adolescents with 
SCH with and without comorbid PDD. 	  
mean SD range mean SD range Sig.
Schizophrenia with comorbid PDDSchizophrenia only
The mean age (months) of the 
adolescent when parents became 
worried
129.6 61.3 36–204 62.3 50.7 12–168 p=0.012
The number of developmental skills 
delayed 2.3 1.5 1–6 12.3 10.3 3–35 p=0.001
Total amount of specific skills delayed 12 42 p < 0.001
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Parents of SCH adolescents with no comorbidity reported they became worried for 
the first time about their child’s development at a significantly later age than parents of 
adolescents with comorbid PDD (Table 10). 
Adolescents without comorbidity had significantly fewer delays in specific 
developmental skills than adolescents with comorbidity. Table 1 in Article III reveals 
that the comorbid group had delays significantly more often for three specific skills, 
which were: cooperative play, role play with their age peers and reading their first book, 
than adolescents without comorbidity. The effect sizes showed either relatively strong 
or strong associations. 
As seen in Table 10 adolescents without comorbidity exhibited significantly lower 
total amounts of different developmental delays than adolescents with comorbid PDD.  
 
4.4 Study IV: Neurocognition and social cognition among those 
adolescents with SCH, a PDD and both disorders  
The SCH group without comorbidity performed significantly worse in neurocognitive 
subtests in Picture Completion than did the SCH group with comorbid PDD and 
adolescents with PDD only. The SCH group without comorbidity performed 
significantly worse at Object Assembly than did the group with PDD only. The 
performance of the SCH group without comorbidity and the SCH group with comorbid 
PDD group was marginally poorer at Coding B testing than that of the group with PDD 
only. Other pairwise comparisons were non-significant (see Table 11).  
 
Table 11.  WISC-III subtests' raw scores (mean, SD) and the differences in scores between the three 
groups controlling for age and gender. 
 
Variable Schizophrenia Schizophrenia + PDD PDD F p p-values (fdr) partial η²
Neurocognition
Information 20.43 (1.45) 21.03 (1.59) 21.78 (1.03)
Similarities 22.08 (1.53) 20.13 (1.68) 23.23 (1.09)
Arithmetics 20.99 (1.08) 17.76 (1.19) 20.03 (0.77)
Comprehension 24.75 (1.73) 22.39 (1.89) 23.55 (1.23)
Picture Completion 19.15 (0.99) 23.86 (1.09) 23.06 (0.71) F(2,24) = 6.52 0.005 0.031 0.345
Coding B 49.61 (5.42) 45.72 (5.94) 63.12 (3.86) F(2,24) = 4.12 0.042 0.102 0.214
Block Design 47.21 (3.35) 49.97 (3.68) 54.45 (2.39)
Object Assembly 26.19 (2.12) 32.74 (2.33) 34.26 (1.51) F(2.24) = 5.10 0.011 0.035 0.304
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There were significant differences in the NEPSY-II ToM verbal test results of the 
social cognition subtests (see Figure 1). The SCH group without comorbidity performed 
significantly worse than did the group with PDD only. The groups did not differ for the 
other two tests that measured social cognition.  
 
	  
Figure 1. Mean T-scores (±SEM) on social cognition tasks of 15 adolescents with PDD only (PDD), 
8 with SCH and a comorbid PDD (SCH + PDD), and 9 adolescents with SCH (SCH).   
 
* p< 0.05 
 
SEM = standard error of mean 
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5 DISCUSSION 	  
The purpose of this research was to study adolescent patients with SCH. The primary 
aim was to assess possible comorbidity of SCH with PDD. Eight adolescents out of a 
total of 18 (44%) patients with SCH fulfilled the diagnostic criteria for a comorbidity of 
some of the PDDs in childhood in our sample. In addition, all 18 SCH patients had one 
or more symptoms of PDDs in adolescence. These principal results are in line with the 
previous findings, which show that these disorders can occur together and they also 
share similar symptoms.   
A secondary aim was to compare the nature and the occurrence of delays in 
developmental skills and catatonic features among two groups. The two groups in this 
study were adolescents with SCH and comorbid PDD and adolescents with SCH only. 
We also compared neurocognition and social cognition between three groups of 
adolescents, namely: those with SCH with and without comorbid PDD and adolescents 
with PDD only.  
Some evidence was found that suggest that those SCH adolescents with comorbid 
PDD may have the following characteristics: earlier onset of symptoms, more numerous 
and larger variety of catatonic features, more delays in development skills and different 
profiles in their neurocognitive abilities and disabilities compared to SCH adolescents 
without comorbidity. We are not aware of published studies in which developmental 
skills, catatonic features or neurocognition and social cognition have been compared 
between these patient groups. 
 
5.1 Comorbidity of SCH and PDD among adolescents 
Forty four percent (8/18) of adolescents with SCH in Study I had a diagnosis of PDD in 
childhood when assessed retrospectively. This result is in line with previous findings for 
COS in which 25–50% of SCH patients were found to have PDD preceding the onset of 
SCH (Hallerbäck et al., 2012; Rapoport et al., 2009; Sporn et al., 2004). Table 2 of 
Article I shows that two SCH patients had typical AS which had originated in early 
childhood. One other SCH patient suffered from AS, which had developed into an 
unspecified PDD because the diagnostic criteria for reciprocal social interaction were no 
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longer met for that patient after 10 years of age. Two patients had childhood autism and 
three other patients had atypical autism in childhood. Children with autistic disorder can 
also have normal IQ scores (Fernell & Gillberg, 2010). In our sample all adolescents 
had primary IQs of over 70. The reason why two adolescents fulfilled the criterion for 
childhood autism was the delay in their language development. Four adolescents 
experienced the onset of psychotic symptoms before or at 12 years of age. One of these 
four had childhood autism, one had AS and one had atypical autism and the fourth did 
not have comorbid PDD. 
However, the correct diagnosis of PDD in childhood was not obtained for most of 
the participants in Study I before the onset of psychotic symptoms and the diagnosis of 
SCH in adolescence. Most of these patients had been examined for developmental 
problems or had received special education in childhood, but they had not received a 
comprehensive assessment for comorbidities. None of the three subjects who fulfilled 
the diagnostic criteria for AS had got the diagnosis in childhood, although in one case 
there was a suspicion of PDD at the age of 10. Often children with AS are not 
diagnosed until 11 years or sometimes even later (Cederlund & Gillberg, 2004; Frith, 
2004; Howlin & Asgharian, 1999). More education is clearly needed for pediatric and 
child psychiatric services to be able to make an earlier diagnosis of PDD in children.  
It has been reported by other studies that COS patients with PDD do not differ from 
SCH-only groups with respect to age of onset of psychotic symptoms, IQ, level of 
functioning or other demographic parameters (Rapoport et al., 2009; Sporn et al., 2004). 
Some children may adapt quite well to their deficits caused by PDD but may develop 
florid psychotic symptoms during adolescence (Gillberg et al., 1986). Sometimes the 
symptoms of PDD, especially among those of high-functioning patients, are difficult to 
notice because the patients manage to compensate for their deficits and seem to manage 
quite well. Sometimes the existence of AS is hidden because of a good environmental 
support (Frith, 2004). The result showed that ASD was correctly diagnosed in only 
about 60% of school-aged children who “really” had ASD in a population study of 
children of five to nine years of age that was conducted in the UK (Baron-Cohen et al., 
2009). The prognosis for EOS is often poor (Clemmensen et al., 2012; Hallerbäck et al., 
2012; Rapoport et al., 2009) and PDDs tend to be lifelong conditions, which in the long 
run facilitate adverse impacts of comorbidities on global functioning. Therefore, it is 
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important to pay attention to both diagnoses when planning treatment for these 
adolescents.  
At present it seems that although patients with SCH often have PDD in childhood, 
the development of SCH in subjects with PDD is quite rare. Nosological confusion and 
possible referral bias generate conflicting evidence regarding the frequency of SCH in 
patients with PDD (Skokauskas & Gallagher, 2010). Reports show that 0–3% of adult 
patients with PDD have comorbid SCH (Abdallah et al., 2011; Hutton et al., 2008; 
Mattila et al., 2010; Stahlberg et al., 2004). Even Hans Asperger had mentioned in his 
classic study that among his 200 ASD patients, only one developed comorbid SCH 
(Asperger, 1944). There is also the possibility that patients with PDD can be mistakenly 
diagnosed with SCH. For example, the symptoms of depression among higher-
functioning PDD children may especially resemble psychotic symptoms (Ghaziuddin et 
al., 1995; Sullivan et al., 2013). It is known that young adults with AS are at high risk 
for depression and anxiety disorders (Lugnegård et al., 2011). 
There is also a risk of making a diagnosis of developmental disorder based only on 
current symptoms. More than half 56% (10/18) of the adolescents with SCH in Study I 
showed current symptoms that were consisted with AS. However, only three of them 
had AS in childhood. Nowadays, documentaries and other programs about AS have 
been widely aired by the media and these have raised public awareness about the 
condition. Therefore, psychiatrists and psychologists treating and assessing adolescents 
frequently meet patients and their families who report symptoms that resemble those of 
AS. In such cases, a wide diagnostic assessment including detailed developmental 
anamnesis in addition to structured psychiatric interviews combined with sound clinical 
judgments are needed to avoid a false positive diagnosis of AS instead of other 
conditions such as SCH.  
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It has been proposed that Multiple Complex Developmental Disorder (MCDD) forms 
a bridge between PDD and SCH (Rapoport et al., 2009). MCDD is described by severe 
early onset deficits in social relationships, thought disorder and affect regulation. It is 
characterized as a subtype of PDD-NOS (Sprong et al., 2008) or a distinct syndrome 
different from PDD (De Bruin et al., 2007). Although the structure of DISCO-interview 
does not allow for direct questions to discern symptoms between those described in 
MCDD, our findings of PDD and SCH do suggest a resemblance to these described in 
MCDD.  
 
5.2 Similarities and differences in symptoms of SCH and PDD  
PDDs share a core triad of abnormalities: (1) qualitative impairments in reciprocal 
social interactions, (2) qualitative impairments in verbal and non-verbal communication 
and (3) restricted social imagination with repetitive and stereotyped patterns of interests 
and behavior (Lugnegård et al., 2011). All 18 patients with SCH had one or more 
symptoms of PDDs in adolescence. As many as 16 out of 18 patients (89%) had 
qualitative abnormality in reciprocal social interaction during adolescence, which was 
most often expressed in a failure to develop peer relationships and a lack of shared 
enjoyment. Moreover, 16 out of 18 patients in adolescence had qualitative impairments 
in communication. An especially prevalent impairment was the relative failure to 
initiate or sustain reciprocal conversation followed by stereotyped, repetitive or 
idiosyncratic language in addition to abnormal content of speech and repetitive themes. 
All these features are common to both PDD and SCH (Ghaziuddin, 2005). Fourteen out 
of 18 adolescents had restrictive, repetitive and stereotyped patterns of behavior, 
interests or activities. This included the need for perfection and items such as  
“arranging objects”, “eats only few foods”, “amasses facts”, and/or “watches the same 
videos”. Many of the adolescents had these repetitive activities especially at the onset of 
treatment in hospital although only two of them were diagnosed with obsessive–
compulsive disorder. Thus, they might have indicated either the schizophrenic process 
or in other cases, the PDD trait. According to a recent study, however, adults with AS 
and adults with schizophrenic psychosis reported higher levels of autistic traits than 
controls in a self-report questionnaire (Lugnegård et al., 2014). On the other hand, the 
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features of autism are also quite common in the general population (Lugnegård et al., 
2014).  
There is a clear overlap between the symptoms of PDD and the negative symptoms 
of SCH. Many subjects with autism have poor social relatedness, anhedonia, flat or 
constricted affect or the ability to show emotions, poor use of gestures and diminished 
eye contact, alogia or poor speech, and the presence of stereotypic behaviors and 
mannerisms (Ghaziuddin, 2005). There is no clear consensus about the qualitative 
nature of single symptoms that might differentiate schizophrenic symptoms from those 
characteristic of PDD (Hallerbäck et al., 2012; Raja & Azzoni, 2009; Raja & Azzoni, 
2010).  
Positive symptoms seen in SCH are not typical for PDD. In his original paper on 
“Autistic psychopathy in childhood” in 1944 Asperger noted: “While the schizophrenic 
patient seems to show progressive loss of contact, the children we are discussing lack 
contact from the start”, and in comments on differential diagnosis: “against this 
diagnosis (SCH) speaks the fact that there is no sign of progressive deterioration, no 
characteristic acute onset of alarming florid symptoms (severe anxiety and 
hallucinations), nor there are any delusions” (Asperger, 1944). These guidelines seem to 
be valid even nowadays.  
 
5.3 Motor problems as a side effects of the medical treatment  
Motor clumsiness is often present in AS according to the ICD-10 classification, 
although it is not included in the actual diagnostic criteria (WHO, 1992). Two out of 
three subjects with AS in our sample presented this feature in childhood. Of the SCH 
adolescents four presented clumsiness in childhood and it continued into adolescence.  
Three of them also belonged to the PDD comorbidity group. An additional five patients 
first started experiencing clumsiness or problems with motor control upon entering 
adolescence. None of these patients had PDD in childhood. This clearly happened for 
three of these five SCH only patients after the administration of antipsychotic 
medication, whereas in other two the potential temporal connection with medication 
could not be verified in patient charts. Moreover, many patients had been prescribed 
several antipsychotic medications, which were often used in combination with each 
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other or with some other classes of psychotropic medications. The overall duration of 
antipsychotic medication treatment was quite short (mean 1.2 years) however. 
According to some preliminary findings (Raja & Azzoni, 2010), patients with comorbid 
PDD and SCH develop motor side effects of antipsychotic medicines more frequently 
than patients affected by SCH only. Another group of authors had previously reported a 
high prevalence of spontaneous acathisia in AS-adults without a history of antipsychotic 
medication (Tuisku et al., 2004), which had possibly rendered them vulnerable to the 
motor functioning impairment side effects of dopamine antagonists.  
In some case reports of adults with both AS and SCH (Raja & Azzoni, 2009), 
antipsychotic medication improved psychotic symptoms, but contrary to what is 
generally observed in SCH, global functioning did not change significantly. It has been 
long known that the core symptoms of PDD-patients respond poorly to medication 
(Ghaziuddin, 2005). 
The DISCO is designed primarily for the detection of qualitative abnormalities in 
development. Therefore, it is not an optimal tool for the assessment of side effects of 
medications, e.g. increase of acathisia or worsening of motor functions during 
treatment. An adequate follow-up of adolescents in our sample is required to see which 
symptoms are best ameliorated in EOS with or without PDD.  
 
5.4 Changes in diagnostic classifications 
There are no restrictions for the comorbidity of Autism spectrum disorder and SCH in 
DSM-5 (American Psychiatric Association, 2013). Earlier diagnostic classifications 
used varying approaches to dealing with this comorbidity. The diagnostic criteria for 
SCH in DSM-IV-TR-classification (American Psychiatric Association, 2000) states that 
“if there is a history of Autistic Disorder or another Pervasive Developmental Disorder, 
the additional diagnosis of SCH is made only if prominent delusions or hallucinations 
are also present for at least a month”. Raja and Azzoni (2010) pointed out that the 
DSM-IV-TR implicitly assumes that a diagnostic criteria for SCH other than delusions 
or hallucinations, may be already met by patients with AS. Similarly, there is no 
restriction for comorbidity of SCH in diagnostic criteria for autistic disorder in DSM-
IV. AS criterion “F” states that “criteria are not met for another specific Pervasive 
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Developmental Disorder or Schizophrenia”. However, a passage in the text states “the 
diagnoses of Asperger’s disorder and Schizophrenia may coexist if the onset of the 
Asperger’s disorder clearly preceded the onset of Schizophrenia”.  
 A meta-analysis of 14 studies on how the DSM-5 impacts upon autism diagnosis, 
found that DSM-5 will probably decrease the number of individuals diagnosed with 
PDD particularly the PDD-NOS subgroup (Kulage et al., 2014). However, no 
significant decrease under DSM-5 was expected for individuals with Autism spectrum 
disorder compared to those who formerly met the diagnosis for AS according the DSM-
IV-TR criteria. There is also a new diagnosis in DSM-5, 315.39 Social (Pragmatic) 
Communication Disorder, which differs from Autism spectrum disorder with respect to 
the following: a lack of restricted/repetitive patterns of behavior, interest, and activities 
during the early development. Some patients who would earlier have been diagnosed 
with PDD-NOS may now fulfill the diagnostic criteria for Social (Pragmatic) 
Communication Disorder. 
There is no statement about comorbid PDD in the ICD-10 criteria (WHO, 1992) for 
SCH. However, it is mentioned in the criteria for childhood autism and AS that the 
clinical picture is not attributable to SCH. 
There have been age limits in place for early language development for PDDs. The 
requirement for AS is that single words are used by two years of age and 
communicative phrases by the age of three years. The use of these age limits as cut-off 
points have been criticized, because these guidelines do not necessarily mean that 
language acquisition is typical. If communicative phrases are used by three years of age 
it does not necessarily mean that language understanding is good (Frith, 2004). These 
age requirements are not stipulated in the diagnostic criteria for Autism spectrum 
disorder in DSM-5. 
In the Study I, the PDD diagnosis was made using ICD-10 classification, which 
currently is the standard classification used in Finland. A new version, ICD-11, is 
expected to be published in the near future, however. As the ICD-classification has 
always been very similar to the DSM-classification it is likely that major revisions 
expected in the version ICD-11 concerning the classification of PDD will be in line with 
DSM-5 descriptions. 
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5.5 Catatonic features 
All 18 adolescents with SCH in Study II presented many lifetime catatonic features. 
This finding is in line with those of previous studies (Green et al., 1992; Thakur et al., 
2003), where children and adolescents with schizophrenic and psychotic disorders 
showed signs of catatonia. Catatonic features in childhood we found in our sample were 
more prevalent among those adolescent SCH patients that had a comorbid PDD than 
those with SCH alone. The difference between these two groups however was no longer 
apparent in adolescence.  
Catatonia and SCH had a common history that reached back to Kraepelins 
description from 1893 to recent years. However, from 1970 onwards SCH and PDD 
have been regarded as different conditions and catatonia remained a feature of SCH but 
not of PDD. Questions about the connection between PDD and catatonia have emerged 
however. Recently, DSM-5 has distinguished catatonia from SCH and regards catatonia 
as a more diverse entity. The classification of catatonia in DSM-5 can now be 
associated either with another mental disorder that emerges as part another medical 
condition, or remain unspecific (American Psychiatric Association, 2013). Both the 
duration and the number of symptoms required for diagnosis varied in earlier 
classifications of catatonia. Several different rating scales for catatonia exist, validated 
in different patient populations and with different items included (Sienaert et al., 2011).   
In the Study II we chose 28 specific catatonic items from the DISCO-interview on 
the base of earlier study by Wing and Shah (2006). In their study Wing and Shah (2006) 
studied catatonia-like features in 200 children and adults with ASD. Those authors 
chose these items on the bases of clinical similarities between catatonia-like behavior 
and the unusual patterns of movement, speech, and behavior found in persons with 
ASD. These features are typically present in early childhood and they have a tendency 
to become less marked with increasing age, especially in more able persons with ASD 
(Wing & Shah, 2006). The number of catatonic features in our Study (II) did not 
significantly change in transition from childhood to adolescence among the SCH 
patients with a comorbid PDD. However, we found the number of catatonic features 
increased significantly in the transition from childhood to adolescence among those 
SCH adolescents without comorbid PDD. In the future, it would be interesting to study 
whether this difference reflects the onset and impact of the SCH process, although other 
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factors, such as antipsychotic medication, may also have contributed to this result. 
More detailed analysis revealed that during childhood, five specific catatonic items 
occurred with a higher prevalence in SCH patients with a comorbid PDD than those 
without comorbidity. The five items were the following: “lacks facial expression”, 
“delayed echolalia”, “odd intonation”, “destructive behavior” and “strips in public”. 
However, the items “lacks facial expression” and “stripping in public” can be regarded 
as qualitative impairments in reciprocal social interactions, whereas “delayed echolalia” 
and “odd intonation” can be regarded as qualitative impairments of verbal and non-
verbal communication.                          
This finding leads, at least partially, to a circular argument. “Lacks facial expression” 
and “stripping in public” can be regarded as qualitative impairments in reciprocal social 
interactions and “delayed echolalia” and “odd intonation” as qualitative impairments of 
verbal and non-verbal communication. Patients with PDDs also exhibit repetitive and 
stereotyped patterns of behavior, and when those are prevented the patient may get very 
anxious and sometimes even destructive. Wing and Shah (2006) suggested there is an 
overlap between catatonic features and the core symptoms of PDDs. Some risk factors 
have been suggested for catatonia in PDD. Stressful life events often precede catatonic 
symptoms in PDD (Hare & Malone, 2004) and those individuals who have impaired 
language and passivity in social interaction are more likely to have catatonic features 
(Wing & Shah, 2000). It has been suggested that the key issue in diagnosing catatonia 
in autism is the emergence of the “new” symptoms or a “change” in the type and pattern 
of premorbid functioning (Ghaziuddin et al., 2005). 
More than three-quarters of all our SCH adolescents had four catatonic features in 
common during their lifetime: “lacks facial expression”, “odd intonation”, “poor eye 
contact” and “lack of cooperation”, but none of them exhibited any features from the 
“visual fascination” subgroup. Wing and Shah (2006) reported that more than three-
quarters of their patients with ASD shared also these same four catatonic features plus 
the feature called “delayed echolalia”. Those authors also reported that the frequencies 
of features in the “visual fascination” subgroup were very low. Given the fact that the 
authors had a sample of 200 ASD persons of whom only 72 individuals had IQs in the 
average or superior range, it is interesting to note this overlap between their and our 
results. In case studies, those PDD patients with higher intelligence manifested fewer 
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catatonic features (Shorter & Wachtel, 2013). However Wing & Shah (2000) reported 
that there were no significant differences between those PDD patients who showed 
catatonic symptoms and a control group for age, IQ, history of seizure disorder or 
diagnostic subgroup of autism.  
 Wing and Shah (2000) studied 506 referrals to a specialist clinic for ASD and 
reported that 17% of patients aged 15 or older met the criteria for catatonia. The risk of 
developing clinical catatonia has been noted to be about the same in persons with 
autism as in those suffering from affective and psychotic disorders (Kakooza-Mwesige 
et al., 2008). Children with ASD, however, seem to have a higher risk for catatonic 
features than children with learning disabilities or language impairment (Wing & Shah, 
2006). Sometimes PDD has not been recognized until the appearance of the first 
catatonic symptoms. Early recognition of catatonia is important in patients with PDD 
because of psychological and medical treatment (Shah & Wing, 2006).  
There has been discussion about the associations between catatonia, autism and 
SCH. Dhossche (2004) proposed that autism could be an early expression of catatonia 
because of a common genetic etiology. Genetic studies also show an overlap between 
PDD and SCH (Rapoport et al., 2009). It has been suggested that autism, catatonia and 
psychoses in children are different manifestations of a single underlying form of brain 
pathology (Shorter & Wachtel, 2013). These three diagnoses had all been routinely 
applied to children and adolescents in the 1920s. Nowadays these three diagnoses are 
considered to be independent disease entities. After evaluating both historical case 
vignettes and modern cases, Shorter and Wachtel (2013) proposed that these three 
illnesses may form what they called an “iron triangle”.  
 
5.6 Developmental delays 
A total of 43 developmental skills and possible delays in their acquisition were assessed 
in Study III. The median number of skills with a delay was three for all the SCH 
adolescents. 
All 18 adolescents with SCH in our study exhibited some developmental delays, 
which was in line with our hypothesis. The most prevalent developmental delays were 
in the areas of gross and fine motor development, speech development, social 
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interaction and play. These results are in agreement with those of earlier studies that 
found early delays in the development of certain skills among those who later 
manifested AOS (Cannon et al., 2002; Isohanni et al., 2000; Jones et al., 1994; Walker 
& Lewine, 1990). However, children who are diagnosed with either COS or EOS are 
reported to have more frequent and more severe problems in language/speech, social 
skills and motor development with a more insidious onset than those who have AOS  
(Alaghband-Rad et al., 1995; Jones et al., 1994; Nicolson et al., 2000; Vourdas et al., 
2003). 
We also hypothesized that the nature and number of developmental delays would be 
much the same among SCH adolescents with and without a comorbid PDD. Contrary to 
our hypothesis, however, the median number of delays in developmental skills was 
significantly higher among adolescents with SCH and a comorbid PDD than among 
those with SCH alone. We found that those patients with both disorders exhibited a 
significantly larger variety of developmental delays than did those suffering from SCH 
alone.  
All adolescents in our study had an IQ in the normal range. Children with PDD have 
been reported to have more impaired daily living skills and self-help skills compared to 
children with non-autistic developmental delays and that this difference can emerge by 
two years of age (Paul et al., 2014). A significant discrepancy between overall cognitive 
ability and adaptive functioning that favored IQ scores over real-life skills was typical 
for PDD (Bölte & Poustka, 2002). In childhood autism abnormal or impaired 
development is evident before the age of three years according to diagnostic criteria and 
problems may occur in areas of self-help skills, adaptive behavior and curiosity about 
the environment. Motor milestones may be somewhat delayed and motor clumsiness is 
usual. It seems that comorbid PDD is associated with a greater variety and higher 
numbers of developmental delays in adolescents with SCH.  
Only three developmental skills were significantly more delayed among our SCH 
patients with PDD comorbidity than among patients with SCH alone. These three skills 
were “cooperative play”, “role-play with their age peers”, and “reading their first book”. 
Cooperative play and role play with their age peers are known to be typical of children 
with PDDs, due to their serious deficits in the development of the imagination and 
social interaction, thus deficiencies in these are considered as core abnormalities of the 
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disorder group (Lugnegård et al., 2011). A study found that those children at the age 
seven who were later to develop SCH were reported to have more social 
maladjustments than controls (Done et al., 1994). Overreactivity, hostility and 
inconsequential behavior were common especially among boys. It seems that social 
problems in PDD present earlier and some development is delayed, whereas 
development of social skills is not necessary delayed in those who are developing SCH 
but instead may have qualitative abnormality that causes problems in social interaction.  
Those children who later develop SCH are reported to have more internalization 
problems, overreactivity at the age of seven and anxiety before 15 years of age (Cannon 
et al., 2002; Done et al., 1994; Jones et al., 1994). 
Deficits in reading comprehension are common among individuals with ASD with 
normal intelligence (Åsberg et al., 2008). A cognitive style of weak central coherence 
that is typical for PDD has been proposed to affect the ability to give global context-
appropriate answers (Happé, 1994). Children with PDD and normal intelligence show 
discrepancies between actual academic achievement levels and levels predicted by their 
intellectual ability (Estes et al., 2011). More overall deficits in academic achievement 
have been reported among those who later develop SCH compared to controls, but these 
differences were quite small and statistically non-significant (Dickson et al., 2012). 
The mean age of the adolescents at which, their parents first became worried that 
something might be wrong with their child`s development was significantly lower 
among SCH adolescents with a comorbid PDD than among those with SCH alone. This 
difference between our two groups probably stems from the fact that the number of 
developmental delays was significantly higher among those with both disorders than 
among those with SCH alone. Our finding is in line with a recent study that found that 
parents whose children suffered from ASDs became worried about their child´s 
development significantly earlier than did parents whose children suffered from other 
kinds of developmental problems (Veness et al., 2012). However, unlike the results of 
De Giacomo and Fombonne (1998), the parents of only two adolescents in our study 
reported worries before their children reached the age of two.  
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Despite the overlap between the results of genetic and neuroimaging studies and 
between the symptoms of SCH and PDDs, the developmental profiles of adolescents 
with both SCH and PDDs appear to differ substantially from those with SCH alone. We 
are not aware of any earlier published studies in which a direct comparison of 
developmental delays in patients with SCH alone or SCH and PDD combined have 
been made. 
 
5.7 Neurocognition and social cognition 
We compared the adolescent group with SCH only, the comorbid group with PDD and 
an additional a separate group of adolescents with PDD only, in Study IV. We 
hypothesized that problems found in adolescents with both disorders would be more 
severe than in adolescents with isolated disorders. The author is unaware of any 
previously published studies that compared these three diagnostic groups of 
adolescents. 
All three groups exhibited different profiles in their neurocognitive abilities and 
disabilities. Adolescents with SCH only performed worse than did those with PDD only 
in three neurocognitive non-verbal tests in WISC-III that required visual and perceptual 
organization skills. On the other hand, adolescents with SCH only as well as those with 
both disorders experienced more problems with processing speed than did adolescents 
with PDD only. Adolescents suffering from SCH only experienced more difficulty with 
verbal ToM tasks than adolescents with PDD only. Contrary to our hypothesis, the 
comorbid group with PDD did not show more severe symptoms. 
Those neurocognitive subtests that showed differences between the groups required 
perceptual organization, visuo-motor co-ordination, attention and short-term visual 
memory, long-term memory, mental processing speed and motor co-ordination 
(Kaufman, 1994). Our results agree with those of several other researcher groups who 
reported spare visual processing for PDDs and also found that adolescents with AS 
performed better than those with SCH in subtests that required perceptual organization 
(Ghaziuddin & Mountain-Kimchi, 2004; Joseph et al., 2009; Kaufman, 1994; Minshew 
et al., 1997; Samson et al., 2012; Williams et al., 2006). The tendency to process details 
instead of the “big picture”, known as the weak central coherence, may prove helpful 
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for those with PDD in this kind of performance test where main purpose is to focus on a 
missing part of the picture or some detail. However, it has also been reported that 
focusing on details was similar in PDD patients and their controls (Planche & 
Lemonnier, 2011). 
Adolescents with SCH only performed significantly worse than adolescents with 
PDD only in subtests that required perceptual organization, mental processing speed 
and motor co-ordination, a finding that was in line with those of Asarnow et al. (1987) 
and Kaufman (1994). Our finding is also in line with the previous longitudinal studies 
which reported that children who later developed SCH performed significantly worse in 
subtests that required perceptual organization, mental processing speed and motor co-
ordination and they also had significantly lower total IQ scores than those who 
remained healthy (Stirling et al., 2003, Sørensen et al., 2010).  
We found that adolescents with SCH only performed worse than did those with PDD 
only in subtest that required sustained attention, short-term visual memory, mental 
processing speed and visuomotor co-ordination. This finding is in line with the 
generally held view that slow information processing is a central feature of the cognitive 
impairment observed in SCH (Asarnow et al., 1987; Dickinson et al., 2007). It should 
be noted however that the difference was only marginal after the type 1 error correction. 
Our findings are also supported by previous study data that reported young individuals 
who later developed SCH had a greater deficit in test performances that required 
information processing speed than healthy controls and unaffected siblings (Niendam et 
al., 2003; Sørensen, 2006). However, a study by Schneider & Asarnow (1987) found the 
performance of patients with SCH and of those with PDDs had no significant 
differences in this type of test. There are also findings that indicated that children with 
PDDs and high intelligence may perform poorly in this kind of test (Ehlers et al., 1997; 
Siegel et al., 1996).  
To our surprise we found that adolescents with SCH and comorbid PDD performed 
as well as those adolescents with PDD only, and better than adolescents with SCH alone 
in subtests that involved visual processing. The tendency to process details instead of 
the big picture in the comorbid group is helpful because the PDD-related tendencies 
may have improved SCH-related problems in the same individuals. However, in another 
test that assessed perceptual organizational abilities but did not necessarily focus on 
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details, the scores of adolescents with comorbidity were intermediate between PDD 
only and SCH groups. Nevertheless, adolescents with SCH and comorbid PDD obtained 
the lowest scores for a subtest that measured processing speed although it showed no 
differences from the performance of adolescents with SCH. It seems that the PDD was 
not an ameliorating factor for this task. 
The only significant difference occurred in the ToM verbal items that measured 
social cognition. Surprisingly, adolescents with SCH only showed more difficulty in 
this task than did adolescents with PDD only, whereas adolescents with comorbidity 
were intermediate between these two groups. The NEPSY-II verbal ToM items included 
first- and second-order false-belief tasks and metaphors. Some questions appeared in the 
form of a lengthy verbal story. Problems in neurocognition (attention, short-term 
memory, and information processing) may affect SCH patients’ levels of performance 
in this subtest. However the performance of the adolescents with SCH showed no 
difference from that of other patient groups for the Arithmetic subtest, which measures 
the same abilities. Nor did we find differences for any verbal subtests. It seems that 
neurocognitive impairments could not explain this finding in social cognition.  
No differences were found between the groups for NEPSY-II visual ToM items and 
Emotion recognition subtest scoring. We cannot make reliable inferences about the 
normality of the performance due to the lack of a control group. There is, however, 
some evidence that individuals with PDD may not have significant problems in all ToM 
tasks (Korkman et al., 2008). The development of the NEPSY-II involved the study of 
different diagnostic groups, and also in a clinical subpopulation of children with AS, 
and reported that 26.3% of the AS group experienced significant problems in ToM tasks 
(verbal and visual together), compared to 10.5% in the control group (Korkman et al., 
2008). This disparity suggests that many children with AS may perform quite well at 
doing NEPSY-II ToM tasks. Both first-order and second-order ToM tasks can be easy 
for high-functioning persons with PDDs as suggested earlier, but more advanced tasks 
tend to reveal problems (Bowler, 1992; Ozonoff et al., 1991). It has also been argued 
that individuals with AS can perform well in ToM tests with their explicit verbal ability 
and if they have enough time to think of answers, but in real life social situations 
deficits are more evident (Frith, 2004).  
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5.8 Study strengths and limitations 
The strengths of this study include the recruitment of patients on a consecutive basis 
from inpatient units in a geographically defined area. Structured instruments with good 
psychometric properties were used in combination with primary documents from early 
childhood, which are readily available in Finland. The basic diagnostic procedures in 
Finland have proven to be reliable (Isohanni et al., 1997). Delays in developmental 
skills were evaluated more widely in our study than in earlier studies. 
Nevertheless, the study has its obvious limitations. One must bear in mind that the 
parents were asked to recall the childhood behavior of their already adolescent 
offspring. Consequently, such data do not necessarily reflect actual behaviors, but 
subjective memories. These results should therefore be regarded as preliminary.  
COS and EOS are less common than AOS and, unfortunately, the sample remained 
small. This small sample size limits the generalizability of our findings. Moreover, the 
current study may have been underpowered to detect the smaller statistical group 
differences that could have been detected in a larger sample.  
The majority of adolescents in this study were girls, which is not typical for EOS, or 
for PDD. Further, this study lacked a healthy control group. It is also clear that more 
research is needed to clarify the boundaries between SCH and Autism spectrum 
disorder.  
 
5.9 Methodological considerations 
DISCO was mainly developed for diagnostic purposes, and there is actually no option in 
the algorithm to detect the deterioration of various functions or features. We obtained a 
detailed and operationalized qualitative description of various behavioral patterns in 
SCH and PDD patients during the early school years and during adolescence. Our 
adaptation of the DISCO-interview by splitting it into childhood- and adolescence-arms 
has not yet been validated elsewhere. The adaption is, however, in accordance with the 
original structure of this diagnostic instrument and that used in a recent study by 
Hallerbäck et al. (2012), which was similar. In addition, the average developmental ages 
in the DISCO when the child should learn some developmental skills, have been taken 
from the Vineland Adaptive Behavior scale, and Finnish norms are lacking.  
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We used WISC-III and NEPSY-II subtest raw scores for comparisons between the 
groups in Study IV. The reason for this choice of instruments was that these tests have 
standardized scores for up to 16 years of age, but not for older individuals and in our 
study group some of the adolescents were over 16 years. The use of raw scores and age 
as a covariant allowed us to compare the relational difference in the scores between the 
groups. We decided to use same test for all these adolescents, instead of using an adult 
version of Wechsler test for older adolescents, because to do otherwise would have 
rendered the performances in the subtests to be incomparable between the different test 
versions.  
There are many tests available for assessing social cognition, but only few are 
standardized. The problem is also that different studies use different tests to assess the 
same domains of social cognition. It is difficult to compare results of different studies 
with such a diversity of tests. We chose to use the NEPSY-II task for ToM because this 
is the first standardized ToM test in Finnish. Our results for social cognition obtained a 
maximum raw score of 17 for the verbal ToM test and the mean scores of adolescents 
with SCH alone and PDD only were over 15 raw score points. However, with 16/17 raw 
scores for verbal ToM task an adolescent within the age group 16 years six months gets 
one standard point, which defines very poor performance.  
 
5.10 Future directions 
Systematic studies in SCH patients that address the overlap of criteria of MCDD, 
impaired social behavior and the presence of thought disorder in particular, and 
information obtained from DISCO-interview are warranted in the future. This might 
clarify the nosological confusion between the differences and similarities between SCH 
and PDD spectrum disorders that still prevail today. More rigid follow-up of motor side 
effects of antipsychotic medicines using structured instruments designed for this 
purpose such as Barnes acathisia scale, are needed. An adequate follow-up of 
adolescents of our sample is required to evaluate, which symptoms are best ameliorated 
in EOS with or without PDD.  
Further, studies with follow-ups from childhood to adulthood are needed to 
investigate whether differences in the occurrence of clinical catatonia as conceptualized 
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in the DSM-5 between SCH patients with and without a comorbid PDD emerge. The 
same naturally applies to catatonia-like features and their waxing or waning or possible 
exacerbation into clinical catatonia. In addition, the impact of PDDs manifests as more 
frequent and earlier-onset developmental delays, which must be studied from a 
developmental perspective. Shedding more light on these differences will require 
additional studies that compare our current group of patients with PDD patients without 
SCH. In the future it would also be interesting to study differences between our group 
of adolescents with SCH and those who are destined to develop AOS and compare 
delays in their respective development. Then we could say whether or not there are 
more severe and a broader range of developmental delays in EOS than AOS. 
It is clear that more research is needed to clarify the boundaries between SCH and 
ASD. Studying the potential neurocognitive phenotypes with larger patient samples 
could shed light on these intriguing issues. Larger sample sizes of studies would also 
facilitate making valid comparisons between the performances of girls and boys.  
 
5.11 Conclusions 
The findings from this thesis show that adolescents with SCH can have comorbid PDD, 
and usually in clinical work these cases with dual diagnoses are not always easy to 
recognize. Our results are in line with previous findings for COS and AOS patients in 
comorbidity with PDD. Earlier diagnostic classifications, before DSM-5, had variable 
approaches for defining comorbidity of SCH and PDD. Because of that, these two 
disorders may not have been diagnosed together in the past, even if it would have been 
necessary to do so. It seems that patients with a primary diagnosis of SCH and a 
subsequent comorbidity of PDD are more usual than patients with a primary diagnosis 
of PDD and a subsequent comorbidity of SCH. As seen in our Study I, adolescents with 
SCH often have symptoms consistent with AS, although only few of them have fulfilled 
the diagnostic criteria in their childhood, which is a prerequisite for the diagnosis of AS. 
Many of the behavioral symptoms that resemble symptoms of AS, such as negativity 
and difficulties in reciprocal social interaction especially with adults are often typical 
behavior in adolescence. There is a risk for misdiagnosis of adolescents with autistic 
symptoms if a detailed longitudinal anamnesis is not obtained. The current findings 
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highlight the importance for pediatricians, psychologists and primary health care to 
acquire more knowledge about the nature of these disorders, so that reliable diagnoses, 
treatment and rehabilitation can be offered to patients.  
Our Study II found that adolescents with SCH and comorbid PDD show many 
catatonic features in childhood, whereas those without comorbidity seem to develop 
these features first in adolescence. Catatonic features exhibited by adolescents with 
SCH alone resemble those described in persons suffering from PDDs without SCH. 
Whether this reflects the onset and impact of the SCH process remains unsolved. The 
presence of comorbid PDD may alter the profile of symptoms in adolescents with SCH 
to earlier and wider ranging catatonic features than would exhibit in SCH only. There 
has been some divergence in earlier results concerning the prevalence of catatonia, 
because unanimous criteria for catatonia have been lacking. Catatonic symptoms appear 
to vary widely and they also appear to differ between childhood, adolescence and 
adulthood.  
Developmental delays were also frequent in adolescents suffering from SCH. 
Patients with SCH and a comorbid PDD showed significantly greater numbers and a 
wider range of developmental delays than patients with SCH alone. Parents of those 
children with comorbidity became concerned about their children’s development when 
their children were at younger age than the parents of children who had SCH alone. It 
seems that comorbidity brings a wider range of developmental delays into the clinical 
picture of SCH. Past studies on the developmental delays in these patient groups have 
often only evaluated delays in motor or language skills. Our evaluation of delays in 
Study III was more comprehensive than those of those earlier studies. 
Finally, the adolescents with SCH alone, or with PDD as a comorbidity and those 
with PDD only had differing profiles in their neurocognitive abilities and disabilities 
upon testing. The comorbid group seemed to display a combination of the visual 
strengths and characteristic style of PDD with the slow processing speed of SCH in 
their neurocognitive profile. Adolescents who were suffering from SCH experienced 
more difficulty with verbal ToM tasks, which is a finding that neurocognitive 
impairments could not explain.  
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Adolescence is the developmental stage that favors the clinical expression of 
psychotic symptoms (Raja & Azzoni, 2010). Catatonia has been proposed to be fully 
expressed in adolescence in patients with PDD (Wing & Shah, 2000). There are some 
developmental attributes during adolescence that exposes the individuals to clinical 
expressions of different symptoms. For this reason, making reliable diagnoses of SCH, 
PDD or catatonia at this age is especially demanding, and developmental information 
about changes and new symptoms is essential. There may also be differences in how 
symptoms of PDD or SCH are presented between males and females. Our small sample 
size made it impossible for us to compare profiles between genders with any statistical 
validity. This gender issue has often been missed in earlier studies as well. It is 
important to note that in our sample the proportion of females was higher compared to 
earlier studies. 
The attempts to explain how PDD, SCH and catatonia are related to each other 
include concepts such as MCDD and an “iron triangle”. At present we lack information 
about the etiology of these disorders. In the light of current knowledge there is a 
possibility that subgroups such as the MCDD and the “iron triangle” may indeed exist 
and our results add to the understanding of the shared features.  
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